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ABSTRACT
The pH-dependent interactions of pHLIPs (pH (Low) Insertion Peptides) with lipid
bilayer of membrane provides an opportunity to study and address fundamental
questions of protein folding/insertion into membrane and unfolding/exit, as well as
develop novel approach to target acidic diseased tissue such as cancer, ischemic
myocardium, infection and others.

The main goal of the work presented here is to answer the following questions:
-

What is the molecular mechanism of spontaneous insertion and folding of a
peptide in a lipid bilayer of membrane;

-

What is the molecular mechanism of unfolding and exit of a peptide from a
lipid bilayer of membrane;

-

How polar cargo attached to a peptide’s inserting end might affect the process
of insertion into a lipid bilayer of membrane;
How sequence variation will affect a peptide’s interactions with a lipid bilayer
of membrane (partitioning into bilayer at neutral and low pH; apparent pK of
insertion) with the main goal to identify the best pHLIP variants for imaging
and therapy of pathological states such as cancer and others.

It has been demonstrated that pHLIP insertion into a membrane is associated with the
protonation of Asp/Glu residues, which leads to an increase of hydrophobicity that
triggers the folding and insertion of the peptide across a lipid bilayer. The insertion of
the pHLIP is unidirectional and it is accompanied by the release of energy.. Therefore,
the energy of membrane associated-folding can be used to favor the movement of cell-

impermeable polar cargo molecules across the hydrophobic membrane bilayer when
they are attached to the inserting end of pHLIP. Both pH-targeting behavior and
molecular translocation have been demonstrated in cultured cells and in vivo. Thus,
there is an opportunity to develop a novel concept in drug delivery, which is based on
the use of a monomeric, pH-sensitive peptide molecular transporter, to deliver agents
that are significantly more polar than conventional drugs. Understanding the molecular
events that occur when a peptide inserts across a membrane, folds, or exits from it and
unfolds provides crucial information for the development of new drug delivery agents,
as well as improving our understanding of the first step of membrane-associate protein
folding.

The promise of exploiting tumor acidosis as a cancer biomarker has not been fully
realized in clinical practice, even though the acidity has been a known property since
the work of Otto Warburg nearly a century ago. The problem has been to find a
practical way to target acidity. pHLIP reversibly folds and inserts across membranes in
response to pH changes, and this discovery has led to a novel way to target acidic
tissue. Steady state biophysical studies have revealed the molecular mechanism of
pHLIP action, which is based on the increase of hydrophobicity of carboxyl groups
when they become protonated under mildly acidic conditions, leading to peptide
insertion into a membrane. It has been shown that pHLIP can target acidic tissue and
selectively translocate polar, cell-impermeable molecules across membranes in
response to low extracellular pH. As noted in the Molecular Imaging and Contrast

Agent Database (MICAD) at NCBI, a pHLIP labeled with a fluorescent dye, or a PETand SPECT- agents (64Cu-DOTA, 18F, 99Tc) is a marker for in vivo acidity,.
All prior studies in vivo were carried out with the WT-pHLIP sequence and showed
that a good contrast and tumor to blood ratio can be achieved only more than 24 hours
after pHLIP injection, when it has accumulated in the tumor and largely cleared from
the blood. However, for the use of pHLIP-based radioactive imaging agents in the
clinic, a more rapid background signal reduction is absolutely essential. We have
conducted research in order to address this important need, to tune tumor targeting
properties, and to broaden our understanding of the molecular mechanism of pHLIP
action. A family of 16 pHLIP variants has been designed based on chemical and
physical principles and comprehensive biophysical studies were performed with nonlabeled peptides. We have successfully established a set of design criteria and
identified the pHLIP candidates for imaging and therapeutic applications, including
lead compounds for PET/SPECT and fluorescence/MR imaging.
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PREFACE
This dissertation is written in the ‘Manuscript Format’ using the Thesis/ Dissertation
template of University of Rhode Island. There are four manuscripts, each organized
into a chapter. Tables and figures of each manuscript are listed under the
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Abstract
What are the molecular events that occur when a peptide inserts across a membrane or
exits from it? Using the pH-triggered insertion of the pHLIP (pH Low Insertion
Peptide) peptide to enable kinetic analysis, we show that insertion occurs in several
steps, with rapid (0.1 s) interfacial helix formation followed by a much slower (45 s)
insertion pathway to give a transmembrane helix. The reverse process of unfolding
and peptide exit from the bilayer core, which can be induced by a rapid rise of the pH
from acidic to basic, proceeds ~800 times faster than folding/insertion and through
different intermediate states. In the exit pathway, the helix-coil transition is initiated
inside the membrane, and the polypeptide starts to exit when about 30% of the helix is
unfolded (17 ms). These insights may guide understanding of membrane protein
folding and the design of medically useful peptides for imaging and drug delivery.
Introduction
The stability and folding of membrane proteins are strongly constrained by the
formation of secondary structures in the lipid bilayer environment, driven by the
hydrophobic effect and hydrogen bonding. Consideration of these factors has led to
versions of a thermodynamic framework model for the folding and unfolding of
helical membrane proteins (1-5). One concept is that spontaneous insertion and
folding includes the formation of helical intermediates at the bilayer surface, followed
by insertion, and that unfolding includes the same steps, but in reverse order. Because
folding to form a helix is coupled to insertion, a significant experimental challenge in
testing the concepts is to separate the process of peptide partitioning into a membrane
from the folding events leading to secondary structure. We have studied a water-
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soluble membrane peptide, pHLIP (pH Low Insertion Peptide), that binds to the
surface of a lipid bilayer in an unstructured monomeric state at neutral pH (6-12).
Lowering the pH triggers the spontaneous insertion of the peptide across the bilayer
and the formation of a transmembrane helix. Because the pH drop can be
accomplished by rapid mixing, kinetic analysis can be used to examine steps in the
process, and the predictions of the thermodynamic models can be tested.
Results
pHLIP is a remarkable 35-residue peptide found as a transmembrane helix in
bacteriorhodopsin, yet soluble when isolated in aqueous solution. At neutral and high
pHs pHLIP is monomeric at concentrations less than 8-10 M, and equilibrates
between unstructured forms in aqueous solution (state I) and bound to the surface of a
lipid bilayer if one is available (state II) (6, 9) (Figure 1a supplementary information).
In an acidic environment the equilibrium is shifted toward a monomeric
transmembrane helical form (state III) (6, 9), and the process of insertion is
accompanied by an energy release of about 1.8 kcal/mol in addition to the binding
energy (6-7 kcal/mol) locating the peptide at the surface (11). The pKa of the
transition from state II to state III is 6.0 (6, 11). The transmembrane orientation of the
peptide at low pH was previously established by FTIR spectroscopy (6); here, we
additionally confirmed a transmembrane orientation by oriented circular dichroism
(OCD) spectroscopy (Figure 1b supplementary information). A characteristic OCD
spectrum for transmembrane helix orientation was obtained using direct insertion of
pHLIP peptides into supported bilayers (in contrast to earlier experiments, where
bilayers were assembled with membrane peptides (13, 14). The protonation of two
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Asp residues in the transmembrane region leads to an increase of hydrophobicity that
result in the folding and insertion of the peptide across a membrane (8). Increasing the
pH promotes the unfolding and exit of the peptide from the core of the lipid bilayer.
The insertion of pHLIP across a membrane is unidirectional: the C-terminus goes
inside a cell or vesicle, and the N-terminus stays outside (7, 9). Neither partitioning of
an unstructured peptide onto the bilayer surface at neutral pH nor insertion as a
transmembrane helix at low pH promotes membrane fusion or leakage of vesicles, red
blood cells, or cancer cells (7, 8, 10). Fluorescence and CD spectroscopy have been
used to monitor transitions between the states (6, 8, 9). (Figure 1c, d supplementary
information): transmembrane helix is accompanied by the appearance of a
characteristic helical CD signal, and a shift of the fluorescence spectrum maximum
and increase of fluorescence intensity. These signals are the basis of our kinetic
studies.
The pHLIP peptide gives an opportunity to observe membrane-associated transitions
between surface coil and transmembrane helix and vice versa. An enabling advantage
of our system is that an initial state is defined, with the peptide bound to the surface of
a membrane as an unstructured monomer. Transitions were induced by rapid changes
of pH by fast mixing of the aqueous solution of pHLIP pre-incubated with POPC at
pH8.0 or pH4.0 with equal volumes of appropriately diluted solutions of HCl or
NaOH,

respectively.

Membrane-associated

peptide

folding/insertion

and

unfolding/exit were monitored by the changes of CD and fluorescence signals we
previously used to study equilibrium states (Figure 1a-b, d-e). Such parameters
(mostly fluorescence) are widely used for the observation of conformational changes
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that occur in polypeptides interacting with a membrane or detergent (15-18). For fast
fluorescence measurements, a filter was used to capture the emission above 320 nm,
but changes of the entire fluorescence spectrum were also recorded in a global mode
with use of emission monochromator (Figure 1c, f). The obtained in stopped-flow
mode fluorescence spectra clearly show that the increase of fluorescence is
accompanied with shift of position of maximum, which indicative to the peptide
insertion into hydrophobic core of membrane.
Since the pHLIP peptide contains a Pro residue in the transmembrane part, we
speculated that proline might act as a helix breaker and/or exhibit isomerization during
folding. To examine these possibilities, a pHLIP variant was synthesized with Pro
replaced by Ala. We observed that the variant shows some helical structure in solution
at neutral pH (Figure 2 supplemental information), and that vesicle binding of the
variant further promotes the coil-helix transition. Since replacement of Pro led to
changes in solution and in the peptide-membrane interactions, we asked whether the
presence of prolyl isomerase (cyclophilin A), which promotes Pro isomerization (19),
would affect folding and insertion of the non-mutated peptide. Experiments were
carried out at various temperatures. No differences were observed in membraneassociated folding in absence and presence of prolyl isomerase (data not shown), so
we conclude that the proline is simply acting as a helix breaker in solution and on the
bilayer surface. A detailed description of the experimental protocol is presented in the
supplementary section.
To avoid crowding of the peptide on the surface of vesicles (parking problem) we set
the peptide:POPC molar ratio at ~ 1:140 (11). Given the surface binding energy of 6-7
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kcal/mol (from our earlier measurements), the bound to free ratio is ~ 104 to 105, so the
initial state in the insertion experiments is predominantly an unstructured surface
bound state of the peptide (state II, Figure 1 supplementary information). In the
unfolding experiments, the initial state, at low pH, is predominantly a transmembrane
helical configuration of the peptide (>95% state III).
As seen by fluorescence, the entire process of insertion (transition form state II to state
III) upon a rapid drop of pH is found to be well described by a pseudo-first order
kinetics model with 4 consecutive steps involving State II, three intermediates, and
State III:

The rate equations for the time dependence can be written as differential equations:

d I 1 
 k1 I 1 
dt
d I 2 

 k 2 I 2  k1 I 1 
dt
d I 3 

 k 3 I 3  k 2 I 2 
dt
d[I 4 ]

 k 4 I 4  k 3 I 3 
dt
d[I 5 ]

 k 4 I 4 
dt



(1)

These differential equations can be solved analytically and the rate equations
integrated, assuming that the initial concentrations of every intermediate except I1 are
zero. The function used for fitting of the experimental data can be written in general
form as:
6

n2

g (t )   f i I i 

(2)

i 1

where fi are the changes of fluorescence or CD signals associated with the i-th
transition from one intermediate to another, and n is the number of intermediates used
in the model. For the kinetic model with three intermediates the function used to fit the
experimental data is
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(3)

All fluorescence kinetic data were normalized to the initial values, so that f1 was about
1. From steady-state experiments performed at various temperatures we established
that the absolute increase of fluorescence signal induced by the drop of pH was the
same at all temperatures. Therefore, asymptotic values (f5) were chosen to be the same
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for kinetics runs performed at different temperatures, and the values varied from 1.55
to 1.6.
CD folding and unfolding curves (Figure 1a, d) were fitted well using a simpler kinetic
model with one intermediate state:
g (t )  f1 I1  f 2 I 2  f 3 I 3 

For each step, the characteristic times ti

(4)
t  1 
 i
k i 

and contributions (Fi in %) to

the spectral signal (with the total change of the CD or fluorescence signal taken as
100%) are presented on Figure 1. The % contributions to the total signal, Fi, were
calculated according to the formula:
Fi  100

f i 1  f i
f n 2  f1 ,

where i = 1,…, n+1

(6)

The fluorescence kinetic curves measured at various temperatures (Figure 2a) were
fitted using models with one, two or three intermediate states. A model with three
intermediate states (eq. 3) was required for an adequate fit of the experimental data
after taking into consideration some increase of fluorescence signal within the first
few seconds (insert in Figure 2a). Starting with the inserted helix, an increase of pH
led to a short delay (about 12 ms) followed by a decrease of the fluorescence signal.
The fluorescence decay reporting the helix-coil exit pathway was well fitted by a
kinetic model with one intermediate (eq. 4). Kinetic parameters obtained from the
fitting of fluorescence kinetic data recorded at various temperatures are presented in
Table 1. Increasing the temperature speeds up the process of insertion, presumably as
a result of increased thermal fluctuations.
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Using kinetic measurements at various temperatures, the activation energies Eia for
each transition were calculated from Arrhenius plots (Figure 2b) according to the
Arrhenius equation:
ln k i  

E ia
RT

(6)

where ki are the rates presented in Table 2; R is the gas constant; T is the absolute
temperature. Assuming that the transition from one intermediate to another occurs
through a single transition state, the Eyring equation can be applied for the calculation
of the activation enthalpy ΔHi# and the activation entropy ΔSi# associated with the
transitions from one intermediate to another:.
#
#
 hk i 
H i
S i
  
ln 

RT
R
 k bT 

(7)

The activation Gibbs free energy, ΔGi# is then:
#

#

Gi  H i  TS i

#

(8)

where h is Planck’s constant and kb is Boltzmann’s constant. Thermodynamic
activation parameters are summarized in Table 2 and their changes during the
transition from one state to another are presented in Figure 2c.
Discussion
To interpret the results, we have constructed a model that is based on and consistent
with the data, but which is incompletely constrained by it. Thus, some features are
viewed with confidence while others are less certain. The model assumes single
pathways of insertion and exit, and is shown in figure 3. Starting with the surface
bound peptide of State II, and following the drop in pH, we see a rapid formation of
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helix, in two steps (Folding intermediates 1 and 2, forming at 8 ms and 112 ms), each
producing about half of the total helix. The helix might be a single straight helix, or it
might consist of several short helices with breaks in between (these possibilities are
experimentally indistinguishable). This part of the interpretation is secure: helix
formation clearly is faster than most of the fluorescence changes. It is possible that
helix rotational orientation or a slight sinking of the helix at the interface could
account for the fast (28ms) first fluorescence change of ~23%. Following the rapid
helix formation, the rest of the insertion process is reported by fluorescence, and is
about 1500 times slower, occurring in three kinetically distinct steps over the next
~45s.
While we cannot be certain of the exact nature of the kinetic intermediates during
insertion, we suggest a few thoughts as working ideas.

From the surface helix

formation to the fully inserted transmembrane helix, two intermediate states are
apparent, folding intermediates FI3 and FI4. Some features of the process to consider
are that significant rearrangement of lipid must occur during the peptide insertion, that
the polar C terminus of pHLIP must traverse the bilayer, and that the proline may
provide a point of flexibility. Our previous studies showed that there is substantial
lipid perturbation when the peptide is in its surface bound configuration, and that the
perturbation is much reduced when pHLIP adopts its transmembrane configuration (8,
10, 11). It is possible that a large collective lipid reorganization is involved, but we
have no data with which to assess such a possibility. We therefore invoke a bending
and partial insertion of the helix as an idea, suggested by the proline, and sketch the
intermediate shown as FI3. The highest activation energy barrier (see tables) is the
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transition from the third to the fourth intermediate, although all of the energy barriers
are significant (hence the slow kinetics). It may be that the fourth intermediate is a
transbilayer inserted form with the C terminus across the bilayer, or that the Cterminus crosses the bilayer during the last transition. We have no direct evidence to
choose one of these, but we know that the C-terminus must cross the bilayer at some
point. Each step from the unfolded to the folded state is associated with a decrease of
entropy (decrease of disorder) that reflects the process of folding (ordering). It is
possible that both the peptide and the lipids undergo a disorder – order transition.
In contrast with previously proposed theoretical models suggesting that entry and exit
pathways mirror each other, our data reveal that the folding and unfolding processes
can have different rates and proceed via significantly different intermediate steps. The
unfolding and exit of the peptide in response to a sudden pH increase occurs within
one hundred milliseconds, orders of magnitude faster than insertion. Assuming that the
increase of pH leads to the deprotonation of the Asp residues (perhaps involving
proton transfer from Asp86 to Arg83, known to happen in bacteriorhodopsin, from
which the pHLIP peptide is derived (20, 21)), followed by the helix-coil transition and
a rapid exit of the polypeptide from the bilayer interior. Surprisingly, about 30% of the
helix-coil transition is completed within ~12 ms, while practically no change of the
fluorescence signal is observed, indicating that the polypeptide remains in the
membrane interior as an unfolding intermediate (UI1). Thus, partial unfolding of the
TM helix, involving about 5-6 residues out of 20-22 residues, occurs inside the
membrane and the peptide subsequently moves out of the bilayer interior. Further
propagation of the helix-coil transition is accompanied by a rapid exit of part of the
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polypeptide within the next 5 ms (UI2). The remaining 30% of the membraneembedded helical structure unfolds and exits within 65 ms (including the C terminus),
and equilibrium is established between pHLIP in its unfolded membrane-bound (Um)
and soluble forms. Unfolding experiments carried out at 7°C showed that the peptide
exit also occurs in two steps with characteristic times of 17.6 and 152 msec (data not
shown).

An interesting possibility is that the two deprotonation steps happen

separately, and account for steps in the exit pathway.
The existence of interfacial folded intermediates reported by several authors has been
based on indirect measurements (22-24), and the results of molecular dynamics
simulations of membrane-associated folding and insertion of various peptides are not
definitive (25-28). Here, we present a direct observation of the formation of an
interfacial helical intermediate as a step in the process of folding and insertion of a
peptide into a membrane.
We conclude that an interfacial helical intermediate is a required step during the
process of pHLIP folding/insertion. Helix formation reduces the free-energy penalty
associated with the partition of the peptide backbone into the low dielectric
environment of the bilayer, despite the fact that the coil-helix transition is associated
with a loss of entropy. Helix insertion, most probably, is accompanied by a significant
perturbation of lipids, although the lipid perturbation is reduced in the overall process.
The insertion of pHLIP is slow, since the peptide is initially located on the outer
leaflet of the bilayer, and it takes time to cross the membrane and reorganize lipids
around the transmembrane helix. In contrast to the insertion, unfolding and exit occur
much faster, perhaps since the peptide can be conceptualized as occupying a small
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channel across the lipid, so that the peptide can quickly exit without significant lipid
reorganization. Such a channel would close immediately after exit of the peptide. We
have demonstrated in vivo that pHLIP can target diseased tissues with elevated levels
of extracellular acidity, such as tumors (8, 12, 29) and that the energy of the insertion
events can be used for the selective translocation of polar cell-impermeable cargo
molecules across the membranes of liposomes and cells (7, 12). Our kinetic data
provide insights on the mechanisms of membrane-associated polypeptide folding and
unfolding, and may be useful in improving the design of peptide based transmembrane
delivery agents
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Tables
Temp.

k1, s-1 (F1, %)

k2, s-1 (F2, %)

k3, s-1 (F3, %)

k4, s-1 (F4, %)

adj R2 / RMSE

7°C

>40 (13.0)

0.48 (13.7)

0.050 (39.4)

0.0110 (33.9)

0.99998 / 4.08E-4

11°C

>30 (18.0)

0.52 (14.2)

0.053 (37.8)

0.0131 (30.0)

0.99998 / 4.05E-4

18°C

>30 (21.2)

0.69 (16.8)

0.071 (32.4)

0.0196 (29.6)

0.99997 / 4.86E-4

25°C

>35 (23.1)

0.89 (16.3)

0.106 (27.5)

0.0242 (33.1)

0.99996 / 5.27E-4

37°C

>35 (23.0)

1.83 (18.2)

0.266 (27.7)

0.0454 (31.1)

0.99963 / 1.46E-3

Table 1. The transition rates, ki, (fractional contributions, Fi) and goodness-of-fit
(adjusted R-square, adjR2, and root mean squared error, RMSE), were obtained by
fitting the fluorescence kinetic curves measured at various temperatures presented in
Figure 2a and using equation (3). The rates k2 – k4 have relative 95% confidence
bounds of 1% or better. Due to an insufficient number of experimental points within
first 50 ms, only a lower bound was estimated for the first rate (k1).
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ΔEa, kcal/mol
‡

I1 → I2 a

I2 → I3

I3 → I4

I4 → I5

-0.4 ± 0.8

7.1 ± 0.8

9.1 ± 1.2

7.4 ± 0.4

-1.0 ± 0.8

7.7 ± 0.8

9.7 ± 1.3

8.0 ± 0.4

‡

-54.7 ± 2.9

-34.8 ± 2.7

-32.1 ± 4.3

-40.8 ± 1.3

‡

15.4

17.5

18.7

19.6

ΔH , kcal/mol
ΔS , cal/(K·mol)
ΔG , kcal/mol at 25°C

Table 2. Activation thermodynamics parameters are presented for the transitions from
one intermediate to another during the process of folding and insertion. The activation
energy, Eai, was calculated from the Arrhenius plots (Figure 2b) according to the
Arrhenius equation (6). The activation enthalpy ΔHi# and the activation entropy ΔSi#
were calculated according to the Eyring equation (7). The activation Gibbs free
energy, ΔGi# at 25°C was calculated according to the formula (8).
a

the data presented for the first transition are not statistically significant, since the

correlation coefficient R < 0.5 and the p-level p > 0.3. All parameters calculated for
other transitions are statistically significant, R > 0.973 and p < 0.0053.
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Figures

Figure 1. Membrane-associated pHLIP peptide folding and insertion across a POPC
bilayer (a-c) and unfolding and exit (d-f) from the core of the bilayer were monitored
by stopped-flow CD and fluorescence. Polypeptide folding and unfolding were
induced by the rapid mixing of pHLIP-POPC solutions with diluted HCl or NaOH to
give pH4 or pH8, respectively. The changes of intensity of CD (a, d) and fluorescence
(b, e) were recorded at 225 nm (CD) and through a 320 nm cutoff filter using an
excitation wavelength of 280 nm (fluorescence). The fluorescence signal recorded
over 80 sec was corrected for photobleaching. The CD and fluorescence data were
fitted by kinetic models with one and three intermediate states by using equations (3)
and (4) (the fitting curves are red). The changes in the entire fluorescence spectrum
during folding (c) and unfolding (f) were recorded in a global mode with the emission
monochromator at the excitation wavelength of 275 nm to minimize the contribution
of the scattered light component at short wavelengths (spectra were corrected for the
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instrument sensitivity). The characteristic times (ti) and fractional contributions (Fi)
are obtained by the fitting of the experimental data using equations (3) and (4). The
experiments were carried out at 25°C. The details of the experimental protocol can be
found in the supplementary information.
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Figure 2. a) The membrane-associated pHLIP peptide insertion across the lipid
bilayer of POPC vesicles was monitored by changes of the fluorescence signal through
a 320 nm cutoff filter at an excitation wavelength of 280 nm and at various
temperatures. The fitting curves obtained at various temperatures are color coded. The
data were fitted by the kinetic model with three intermediates by using function (3). b)
The Arrhenius plot was constructed according to the Arrhenius equation (6). c) The
changes of the activation energy, Eai, enthalpy ΔHi#, entropy ΔSi# and Gibbs free
energy, ΔGi# for each transition are plotted. The values of the thermodynamic
activation parameters are presented in Table 2.
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Figure 3. A schematic interpretation of the membrane-associated folding and
unfolding events suggested by the kinetic data. The pHLIP peptide starts as a surface
bound coil at pH8. A rapid drop of pH to 4 causes a rapid formation of helical
structure on the surface, followed by a much slower insertion of the helix across the
bilayer, with several kinetically distinct intermediates for which speculative models
are shown. A sudden elevation of the pH from 4 to 8 results in the rapid unfolding and
23

exit of the peptide via a different pathway with different intermediates. The
characteristic times (ti = 1/ki) were calculated from the rates presented in the Table 1.
See discussion in the text.
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Supplementary information
Methods
pHLIP peptide
The pHLIP sequences: AEQNPIYWARYADWLFTTPLLLLDLALLVDADEGT and
its Pro to Ala variant AEQNPIYWARYADWLFTTALLLLDLALLVDADEGT were
prepared by solid-phase peptide synthesis using Fmoc (9-fluorenylmethyloxycarbonyl)
chemistry and purified by reverse phase chromatography at the W.M. Keck
Foundation Biotechnology Resource Laboratory at Yale University. For use of the
peptide, the lyophilized powder is dissolved in a solution containing 3 M urea and
transferred to 10 mM phosphate buffer, pH8.0 using a G-10 size-exclusion spin
column. The concentration of the peptide was determined by absorbance (ε280=13,940
M-1cm-1).
Vesicle preparations
Large unilamellar vesicles (LUVs) were prepared by extrusion. 1ml of 25 mg POPC
(1-Palmitoyl-2-Oleoyl-sn-Glycero-3-Phosphocholine, Avanti Polar Lipids, Inc.) in
chloroform was desolvated on a rotary evaporator and dried under vacuum for several
hours. The phospholipid film was rehydrated in 10 mM phosphate buffer, pH 8.0,
vortexed for 2 hours, and repeatedly extruded through a 50 nm membrane to give
small unilamellar vesicles.
Steady-state fluorescence and CD measurements
Steady-state fluorescence measurements were carried out on a PC1 spectrofluorometer
(ISS, Inc.) under temperature control. Peptide fluorescence spectra were recorded from
310 nm to 400 nm with the spectral widths of excitation and emission slits set at 2-4
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nm and 2 nm, respectively, using an excitation wavelength of 275, 280 and 295 nm.
The changes of fluorescence signal in process of transition from one state to another
are independent of the excitation wavelength, which indicate that the contribution of
Tyr fluorescence into spectra is minimal. The polarizers in the excitation and emission
paths were set at the “magic” angle (54.7o from the vertical orientation) and vertically
(0o), respectively, in order to reduce Wood’s anomalies from the reflecting
holographic grating. Steady-state CD measurements were carried out on a MOS-450
spectrometer (Bio-Logic, Inc.) under temperature control. The CD spectra were
recorded from 185 nm to 270 nm. All measurements were performed at 25oC unless
otherwise indicated.
OCD measurements
For oriented circular dichroism measurements we prepared the supported bilayer on
quartz slides with spacers of 0.2 mm thickness on one side with special polish for far
UV measurements (Starna). The cleaning slides included the following steps 1)
soaking in cuvette cleaner solution for 5-10 min, 2) rinsing with de-ionized distilled
water, 3) sonicating for 10 min in 2-propanol, 4) sonicating in acetone, 5) sonicating in
2-propanol once again, 6) rinsing with de-ionized water, 7) soaking for 30 min, first,
in 30% hydrogen peroxide, 8) and, later, in 70% sulfuric acid, 9) rinsing with Milli-Q
purified water. A POPC lipid monolayer was deposited on a quartz substrate by the
Langmuir-Blodgett (LB) method using (KSV minitrough). For the LB deposition, a
clean wet slide was immersed vertically into the clean subphase (Milli-Q purified
water kept at 25 °C) of a Langmuir-Blodgett trough. Then small amount of POPC
lipid in chloroform was spread on the surface of the subphase and allowed solvent to
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evaporate for about 20 min. Next the monolayer was compressed to 32mN/m. When
the surface pressure was stabilized the slide was pulled out form the subphase with
speed of 10 mm/min. The second layer was created by fusion with POPC vesicles.
About 60 l of LUV vesicles (100 nm in diameter, lipid concentration of 2 mM) was
spread on the slides for 30 min, then slides were rinsed carefully and filled with pH 4
phosphate buffer (80 l of buffer for each slide).The slides were stacked together
while filling with the buffer to have a complete set of 12 slides (24 bilayers). The
spacers between slides kept them form the sticking to each other. The quality of the
supported bilayers were accessed in separate experiment by using fluorescent vesicles
for fusion, and analyzing roughness of the obtained supported bilayer under the
fluorescent microscope (Olympus IX71). Once the blank OCD spectrum was
measured the slides were carefully disassembled and filled with phosphate buffer pH4
containing 10 M pHLIP peptide and the OCD spectrum of the sample was recorded.
The blank spectrum was subtracted from the sample spectrum to get final line
presented in Figure 1b supplementary information.
Stopped-flow fluorescence and CD measurements
The stopped-flow fluorescence and CD measurements were carried out on a SFM-300
mixing apparatus connected to a MOS-450 spectrometer (Bio-Logic, Inc.) under
temperature control. The FC-20 and TS-100/15 observation cuvettes were used for the
fluorescence and CD measurements, respectively. All solutions were degassed several
minutes under vacuum before loading into the syringes to minimize air bubbles. The
pHLIP was pre-incubated with POPC at pH8.0 to reach equilibrium and
folding/insertion was induced by fast mixing (5.7 ms dead time) of equal volumes of
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pHLIP-POPC pH8 and appropriately diluted HCl, to obtain a drop of pH from 8 to 4.
In the unfolding experiments, pHLIP was pre-incubated with POPC at pH8.0, then
HCl was added to lower the pH to 4.0, and time was allowed for equilibration
(minutes). Unfolding was induced by mixing equal volumes of pHLIP-POPC pH4 and
NaOH diluted to increase the pH from 4 to 8. The concentration of the peptide (7 M),
lipids (1 mM) and mixing conditions (6.5 ml/sec flow of each solution) were
optimized to ensure i) the proper rapid mixing of the entire volume of the sample to
get the target changes of pH (from pH8 to pH4 and vice versa); ii) the best signal to
noise ratio and iii) the minimal disruption of liposomes, which was assessed by
changes of the scattered light signal. At the peptide: lipid ratio of 1:142 we used in
these experiments, the equilibrium binding strongly favors the membrane-bound state
II (by 6-7 kcal/mol according to our previously published thermodynamic studies11).
Changes of the pHLIP fluorescence signal were recorded through a 320 nm cutoff
filter using an excitation wavelength of 280 nm. The fluorescence signal, recorded
over 80 sec, was corrected for photobleaching. Changes of the scattered light signal
from the liposomes were recorded through the 320 nm cutoff filter using an incident
wavelength of 320 nm. Each kinetic curve was recorded several times and then
averaged, excluding the first 3-4 shots. The shift of the entire fluorescence spectrum
during folding/unfolding was also recorded in a global mode using an emission
monochromator, with an excitation wavelength of 275 nm to minimize scattered light
at short wavelengths (in a separate experiment the spectra were recorded with 280 nm
of the excitation wavelengths).

Each spectrum was recorded several times and

averaged. All spectra were corrected for the spectral sensitivity of the instrument by
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comparing the spectrum of a tryptophan solution obtained with the same instrument
with a standard tryptophan spectrum. In a control experiment, the signal was measured
from the liposomes in the absence of peptide. At an excitation of 275 nm the scattering
signal was insignificant, even at short wavelengths of the spectra.
The most challenging measurement was to monitor the changes of the CD signal (at
225 nm), which occurred ~100 times faster than the fluorescence changes. About 1520 shots were performed and signals were averaged. The sensitivity might be
enhanced by increasing the peptide concentration. However, there are two serious
obstacles to such an approach: i) at high peptide concentration the equilibrium in
solution is shifted toward aggregated forms, which might differently interact with the
lipid bilayer; ii) any increase of the peptide concentration must be accompanied with
an increase of lipid concentration to fully favor the bound state and minimize amount
of the unbound peptide, but high liposome concentrations result in the appearance of
significant light scattering, which interferes with the CD signal. To reduce light
scattering, small POPC vesicles (~50 nm in a diameter) were used in the study. In a
separate experiment we confirmed that there is no significant difference between the
fluorescence kinetics curves of pHLIP interacting with liposomes of 100 and 50 nm in
diameter. In order to accurately establish the baseline in CD kinetics experiments, we
recorded the signal alteration in response to the pH changes in a mode without
triggering; in this mode the rapid changes could not be monitored and this mode was
used only for the detection of the initial and final states of the process. Thus, the CD
signal reproducibly varied from -5 to -14÷-15 millidegree and vice versa. The baseline
and asymptotic values are important for accurate fitting of the experimental data.
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Stopped-flow fluorescence measurements of the peptide insertion into the lipid bilayer
were performed at various temperatures. All solutions were pre-equilibrated at each
experimental temperature before the measurements.
Since the pHLIP peptide contains a Pro residue in the transmembrane part, we thought
that proline isomerization might occur as part of the folding process. To test this
possibility, a variant pHLIP was synthesized, where Pro was replaced by Ala. The
steady-state fluorescence (excited at 295 nm) and CD spectra were measured in the
absence of lipids at pH8.0 and in the presence of lipids at pH8.0 and 4.0. We observed
that the mutated peptide forms some helical structure in solution, as might be
understood from the role of proline as a helix breaker in some instances. The
formation of helical structure is enhanced in the presence of vesicles. The fluorescence
spectrum of the variant peptide in the presence of lipids at pH8.0 was blue shifted
more (Lmax=338 nm) that for the normal membrane-attached state (Lmax = 342-343).
Since replacement of the Pro residue led to alteration of the peptide-membrane
interactions, we carried out experiments (folding/insertion) at various temperatures in
the presence of prolyl isomerase (cyclophilin A), which catalyses the isomerization of
Pro residues in peptides. pHLIP was preincubated with the cyclophilin A (Sigma) at a
ratio of 1:100 for two hours before mixing with liposomes, and fluorescence (at
various temperatures) and CD kinetics measurements were performed in presence of
cyclophilin A. All data obtained were the same as in the absence of enzyme.
Data analysis
The kinetic equations were solved by integration of (1) in Mathematica 5 (Wolfram
Research). Nonlinear least squares curve fitting procedures were carried out in Origin
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7 and MatLab. The goodness-of-fit was assessed by the aadjusted R-square statistics
(adjR2) and root mean squared error (RMSE) according to the standard formula.
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Figures for supplementary information

Figure 1 supplementary information
a) A schematic representation of pHLIP in solution and interacting with a lipid bilayer
at neutral and low pHs. State (I) corresponds to the peptide in solution at normal and
basic pHs. By addition of vesicles, the unstructured peptide is adsorbed on the
membrane surface, raising the local concentration (State II). A drop of pH leads to the
protonation of Asp residues, increasing peptide hydrophobicity, and resulting in the
insertion and formation of a transmembrane alpha-helix (State III). Lipids interacting
with the peptide directly are marked with blue head groups, lipids influenced by the
interaction but not interacting with the peptide directly have cyan head groups, and
lipids that are not involved in the interaction with pHLIP have yellow head groups. b)
The transmembrane orientation of the helix has been confirmed by OCD. Transitions
between states can be monitored by changes of fluorescence (c) and circular dichroism
(CD) (d) spectral signals. The fluorescence and CD spectra of pHLIP at pH8 (black
lines) indicate an unstructured configuration with tryptophan residues fully exposed to
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solvent. Incubation of pHLIP with liposomes at pH8 (blue lines) induces the partial
burial of tryptophan residues inside the lipid bilayer without helix formation.
Decreasing the pH to 4.0 by the addition of HCl (red lines) induces the insertion of
pHLIP and helix formation

Figure 2 supplementary information
The fluorescence (a) and CD (b) spectra of variant pHLIP with the Pro located in the
middle of the transmembrane part replaced by Ala. Spectra are presented at pH8.0 in
the absence (black lines) and presence (blue lines) of vesicles and at pH4.0 in the
presence of vesicles (red line).
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Abstract
We have used pHLIP® [pH (low) insertion peptide] to study the roles of carboxyl
groups in transmembrane (TM) peptide insertion. pHLIP binds to the surface of a lipid
bilayer as a disordered peptide at neutral pH; when the pH is lowered, it inserts across
the membrane to form a TM helix. Peptide insertion is reversed when the pH is raised
above the characteristic pKa (6.0). A key event that facilitates membrane insertion is
the protonation of aspartic acid (Asp) and/or glutamic acid (Glu) residues, since their
negatively charged side chains hinder membrane insertion at neutral pH. In order to
gain mechanistic understanding, we studied the membrane insertion and exit of a
series of pHLIP variants where the four Asp residues were sequentially mutated to
nonacidic residues, including histidine (His). Our results show that the presence of His
residues does not prevent the pH-dependent peptide membrane insertion at ∼ pH 4
driven by the protonation of carboxyl groups at the inserting end of the peptide. A
further pH drop leads to the protonation of His residues in the TM part of the peptide,
which induces peptide exit from the bilayer. We also find that the number of ionizable
residues that undergo a change in protonation during membrane insertion correlates
with the pH-dependent insertion into the lipid bilayer and exit from the lipid bilayer,
and that cooperativity increases with their number. We expect that our understanding
will be used to improve the targeting of acidic diseased tissue by pHLIP.
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Introduction
Extracellular acidification is a hallmark of different pathologies, including cancer,
inflammation, ischemic stroke, and atherosclerotic plaques. Acidosis might be a useful
biomarker for diagnosis or treatment if means can be found to target tissue acidity. We
have found that a peptide derived from helix C of bacteriorhodopsin,1 named pHLIP®
[pH (low) insertion peptide], is capable of targeting acidic tissues and inserting into
the cell plasma membrane.2 pHLIP is able to target mouse tumors in vivo with high
specificity,2 opening the possibility of its use for cancer imaging. Additionally, pHLIP
has a promising therapeutic potential, as it is able to translocate cell-impermeable
cargo molecules, such as organic dyes, peptides, peptide nucleic acids, and toxins,
across the plasma membrane into the cytoplasm of tumor cells. 2 and 3 pHLIP itself does
not have obvious acute toxicity in cells3 or in mice.2
pHLIP is monomeric at low concentrations, with a mostly unstructured conformation
in neutral and basic solutions (state I). If lipid vesicles or membranes are present at
neutral pH, pHLIP binds to their external surface with an energy of 6–7 kcal/mol (state
II).4 In the membrane-attached state, pHLIP remains largely unstructured.1 However,
if the solution pH is lowered, pHLIP inserts to form a transmembrane (TM) α-helix
(state III). The insertion is fully reversible and unidirectional, with the C-terminus
being translocated across the membrane.3 The pKa of peptide insertion into lipid
bilayers is 6.0, and the energy difference between the attached state and the inserted
state is 1.8 kcal/mol at 37 °C.4
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The pHLIP sequence is relatively rich in acidic residues (Table 1). At neutral pH, the
combined negative charges of these residues, together with the carboxy terminus,
constitute a large energetic barrier to pHLIP insertion across the membrane. The
estimated energetic cost of the transfer of a single aspartic acid residue from water to
the hydrophobic core of the membrane is unfavorable by 3.6 kcal/mol for the
unprotonated (negatively charged) state, but only by 0.4 kcal/mol for the protonated
(noncharged) state.5 Simultaneously moving four charged Asp residues, one Glu
residue, and the carboxy terminus into the membrane would cost 21.6 kcal/mol,
assuming 3.6 kcal/mol for each carboxyl group, and peptide partitioning into the
membrane at equilibrium would be about 1:1016. Thus, for pHLIP to be able to insert
into membranes, protonation of a large fraction of the acidic residues can be expected,
and knowledge of the protonation pattern of the acidic residues of pHLIP is an
essential part of understanding the molecular mechanism of the membrane insertion
process for any peptide containing carboxyl groups. Two classes of carboxyl groups
are of interest: those that remain buried in the membrane after pHLIP is inserted into
the membrane and those that traverse the hydrophobic core of the membrane during
insertion.6 Accordingly, we have studied both the pH-driven membrane insertion and
the exit process for a series of peptides where the key aspartic acid residues are
sequentially mutated.
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Results
Previous studies in our laboratories revealed that sequence variations in the TM region
of pHLIP can disrupt the delicate balance that preserves its water solubility. For
example, a simultaneous change in the two aspartic acid residues at positions 14 and
25 to the homologous glutamic acid (Asp14/25Glu) resulted in a loss of pH-dependent
membrane insertion due to aggregation of the peptide in aqueous solution7 (we have
recently developed new pHLIP variants with several Glu residues, which preserve pHdependent properties; unpublished data). In order to reduce the likelihood that the
introduced variations in the peptides used in this work could cause aggregation, we
decided to follow a dual strategy to increase their water solubility: (i) we added an Asp
tag to the N-terminus (noninserting end) to increase the number of charges in the
molecule, which typically improves the solubility of hydrophobic peptides8 and 9; this
resulted in the replacement of the N-terminal sequence AAEQ with DDDED
(Table 1); and (ii) we used the TANGO algorithm10 to define the region of the pHLIP
sequence with the highest aggregation tendency and found this to be the stretch from
residue 21 to residue 30 (coinciding with the most hydrophobic region of the peptide).
We then mutated Leu26 to Gly, which greatly reduced the predicted aggregation
tendency.
We incorporated these modifications into a series of pHLIP variants, where four
aspartic acid residues were sequentially mutated to nonacidic polar residues. The
aspartic acid residues at the C-terminus of the peptide that transitorily traverse the core
of the membrane upon insertion (Asp31 and Asp33) were replaced with polar but

38

uncharged asparagine residues. On the other hand, for the Asp residues that are located
in the core of the membrane after insertion (in positions 14 and 25), histidine was
chosen as the replacement residue, as it is expected to be partially charged at neutral
pH (thus improving water solubility) while being only slightly polar in its uncharged
state (the transfer energies from water to the bilayer interior are 0.43 and
0.11 kcal/mol for the neutral forms of Asp and His,5 respectively) so that the insertion
properties of pHLIP may not be altered. The peptides were named D0–D3 according
to the number of aspartic acid residues present in the regions of interest (TM and Cterminus; the positively charged N-terminus is not expected to interact with the
membrane). For the variants with three aspartic acids, two alternatives were studied:
one that kept Asp14 (D3a peptide) and the other that kept Asp25 (D3b peptide).
We conducted experiments to test the state of the variants in solution, where pHLIP is
largely found as an unstructured monomer.11 Sedimentation velocity experiments were
conducted to determine the oligomerization state of the different peptide variants in
aqueous buffer. Previous analysis of wild-type (wt) pHLIP (at 7 μM in 10 mM
phosphate buffer and 100 mM NaCl, pH 8)11 showed that pHLIP is mostly
monomeric, but a small oligomer population is observed (∼ 6%). We performed our
sedimentation velocity experiments under the same conditions, but without NaCl in
the solution. For each peptide, we observed a peak with a sedimentation coefficient of
0.72 ± 0.12 S (Table 2 and Fig. 1), which corresponds to a molecular mass of
3.4 ± 0.8 kDa. This is in agreement with the expected monomer masses of the
different peptides (4126 Da for wt and ∼ 4300 Da for the different variants), with the
differences being ascribed to shape effects from the extended peptide. In the case of
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D1 and D0, a minor peak with a sedimentation coefficient of 3.3 ± 0.3 S was also
observed. This component represents 5 ± 2% of the total population, and its
sedimentation coefficient corresponds to a molecular mass of 43 kDa (roughly
consistent with the presence of an octameric or decameric particle). Comparison of our
results with the previous report for wt suggests that the presence of oligomers is
reduced at lower ionic strength. For the particular case of the D1 and D0 peptides, they
seem to have a slightly higher oligomerization tendency in solution, but they are still
95% monomeric. Thus, our results suggest that all the peptide variants remain soluble
and are essentially monomeric. For the rest of the experiments, we employed peptide
concentrations (1.5–5 μM) lower than that used for sedimentation analysis (7 μM);
thus, the level of oligomers present for D1 and D0 is expected to be lower.
Fluorescence spectra of the peptides in aqueous solution at neutral pH showed that, in
all cases, the emission maximum is centered around 347–349 nm (Fig. 2, black lines,
and Table 2), indicating that the two tryptophan residues of the peptides are largely
exposed to aqueous solution, as in fully unfolded proteins, and consistent with the
slightly low sedimentation coefficient. This finding represents an improvement over
the previously studied Asp14/25Glu mutant peptide, where peptide aggregation shifts
the emission maximum to 342 nm in buffer at pH 8.7 A similar fluorescence maximum
was also observed for the Asp14/25Asn mutant under the same conditions.2 The
presence of mostly unstructured species in aqueous solution for each of the studied
peptides was confirmed by circular dichroism (CD) experiments, since the observed
CD spectra were characterized by a minimum at 203 nm (Fig. 3, black lines), as
observed for pHLIP in state I.
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The two lipid-interacting states of the pHLIP variants were then examined: state II,
where wt pHLIP is mostly unstructured and attached at the bilayer surface, and state
III, where wt pHLIP forms a TM helix at low pH.1 and 6 Fluorescence experiments in
the presence of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) liposomes
revealed that for the two D3 variants, the characteristic fluorescence signatures for
states II and III were evident: (i) in the presence of liposomes at neutral pH (Fig. 2,
blue lines), the fluorescence emission maxima of the peptides were slightly shifted
from 348.7 ± 1.0 to 346.2 ± 1.2 nm, accompanied by a small fluorescence increase
(Table 2); and (ii) when the pH was lowered to pH 4, we observed a large fluorescence
increase and a spectral blueshift to 336.2 ± 1.1 nm (red lines), which are typically
observed when the Trp side chain is buried in the membrane hydrophobic core. To
complement the fluorescence data, we performed CD experiments under the same
conditions (Fig. 3). The CD signature of the pHLIP membrane insertion process
consists of the appearance of the characteristic signals associated with the formation of
α-helix: minima at 208 and 222 nm and positive ellipticity at 190 nm. Both D3
variants showed spectral changes very similar to those observed for wt upon
acidification. Thus, we concluded that replacement of one of the Asp residues in the
TM region of the peptide does not lead to changes in the peptide's ability to interact
with the membrane in a pH-dependent manner.
The D2 variant, where both Asp residues are replaced by His residues, also
demonstrates a pH-dependent membrane interaction. However, the spectral pattern is
slightly different from those for wt and D3 variants: the fluorescence intensity of D2
in the presence of POPC decreases in the pH range 8–6, with no significant changes in
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the spectral maximum at pH 8–7 and with a small shift to lower wavelengths at pH 6
(Fig. S1). The amount of the helical structure of D2 at neutral pH is slightly higher
than those of wt and D3 (Fig. 2 and Table 2), while no change is seen in the pH range
8–6. As an explanation, we suggest that D2 partitions somewhat more deeply into the
membrane lipid bilayer than wt and D3 at neutral pH values, since His residues are
expected to be only partially charged at neutral pH values, enhancing the
hydrophobicity of the peptide TM and its affinity for the lipid bilayer. The decrease in
fluorescence signal in the pH range 8–6 might be attributed to the partial quenching of
emission of at least one of the Trp residues by one of the partially protonated His
residues. At the same time, at neutral pH values, the peptide C-terminus containing
four negative charges (two Asp, one Glu, and the C-terminus) does not partition into
the membrane, keeping the peptide at the membrane surface. A further drop of the pH
to pH 3–4 is associated with a fluorescence spectral maximum blueshift, an increase in
fluorescence intensity (Fig. 2), and the appearance of a more pronounced negative
band at 222 nm on CD spectra (Fig. 3), which is usually an indication of peptide
insertion into the bilayer.1 Reduction of pH leads to the protonation of negatively
charged groups at the C-terminus and peptide insertion into the membrane. At the
same time, we expect that protonation of His residues at low pH should occur; this
might lead to the peptide's exit from the lipid bilayer or, alternatively, the formation of
a pore channel in the lipid bilayer, where positively charged His residues would be
pointed toward the channel. Calcein encapsulation control experiments that rule out
the formation of pores in the membrane by the D2 and D3 peptides were performed
(Fig. S2). Thus, most probably, the pKa for the protonation of His is shifted to very
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low pH values when it is embedded in a lipid bilayer. We carried out fluorescence pH
titrations to compare the behaviors of D2 and wt peptides at pH values lower than 3.5
(Fig. S3). While no fluorescence change was detected for wt at acidic pH values, we
observed that an additional process was present for D2 (with an apparent pKa of 2.5),
characterized by a fluorescence decrease and a redshift of the spectral maximum,
which might be associated with peptide exit from the lipid bilayer.
To establish the orientation of each helix in the membrane, we performed oriented
circular dichroism (OCD) measurements in which the light beam is oriented
perpendicular to the planes of a stack of oriented lipid bilayers containing the peptides
of interest. Theoretical calculations and experimental data indicate that helices
oriented with axes parallel with the membrane surface (perpendicular to the incident
light) give CD signals distinctly different from those of helices oriented across the
bilayer (parallel with the incident light).12,

13 and 14

In the range of 190–240 nm, the

peptide CD spectrum is dominated by π–π* and n–π* transitions.15 The π–π* transition
in a helix splits into three components, one of which gives rise to a negative Gaussian
band near 205 nm, with its electric transition dipole parallel with the helical axis.
When the incident light propagates parallel with the helical axis, the electric field
vector is orthogonal to the 205-nm π–π* dipole transition, and there is no interaction
between the electromagnetic wave and the dipole, leading to the disappearance of the
negative band at 205 nm in a CD spectrum. Thus, when the supported bilayers are
oriented perpendicular to the light propagation, a helix with a TM orientation will
have a CD spectrum that contains a positive 190-nm band and a negative 225-nm
band. If the helix adopts a membrane surface orientation on the supported bilayer, then
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all transitions are seen, and the OCD spectrum is the same as for a peptide CD
spectrum in solution, with randomly oriented helices. Our data clearly indicate that D2
adopts a TM orientation at pH 3.5–4.5, while increasing the pH leads to peptide exit
and the appearance of a membrane surface orientation of the helix (Fig. 4). The OCD
spectrum at pH 1.9 does not correspond to a TM helix. Thus, we conclude that the pKa
of both or at least one of the His residues is significantly shifted from 6.3–6.916 to a
lower value (2.5) due to their location at the bilayer interface in state II, emphasizing
the important influence of bilayer surface properties on the pK values of dissociating
groups in interacting peptides. A similar trend was previously observed for peptides
that insert into membranes via the deprotonation of His residues,

17 and 18

although the

magnitude of the pKa shift was smaller. However, large changes in pKa are typically
observed when the side chains are in different environments, as the protonation of
titratable amino acids depends on the dielectric properties of their environment.19 A
fitting example of large pKa changes is found in the native environment of pHLIP,
bacteriorhodopsin, where Asp14 and Asp25 have pKa values of 7.5 and > 9,
respectively,20 significantly higher than the pKa values of 3.7–4.0 found for fully
solvated aspartic acid side chains.16
D1 has one less Asp residue at the C-terminus than D2. The slightly larger blueshift of
fluorescence emission (Fig. 2) and the higher content of helicity observed in the
presence of POPC at neutral pH values (Fig. 3) could be associated with an even
deeper position of the peptide in the membrane. Fluorescence spectral blueshift and
intensity increase, together with an increase in ellipticity at 222 nm, occur upon
acidification; this might indicate protonation of Asp33, Glu34, and the C-terminus, as
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well as peptide insertion into the lipid bilayer. The OCD spectrum obtained for D1 at
pH 3.3 (Fig. 4) does not show a clear TM orientation of the helix: some decrease in
ellipticity at 205–225 nm—which might indicate the existence of a mixture of TM and
surface-parallel orientations of helices or the appearance of a significantly tilted TM
helix—is observed. D0, in contrast to all other pHLIP variants described above, has a
blueshifted maximum of fluorescence emission (Fig. 2) at neutral pH values in the
presence of POPC, with a high content of helical structure (Fig. 3). Virtually no
changes in spectral signal occur for D0 upon acidification (Figs. 2 and 3). The OCD
data primarily reveal a surface orientation of the helix at low pH values (Fig. 4), as
expected for a peptide with no aspartic acids.
To study the magnitude and directionality of the membrane insertion of the peptides,
we used a biotin–avidin binding assay. A biotin moiety was attached to the C-terminus
of each peptide. The level of binding to avidin was measured, and the protection of the
biotin molecule from avidin interaction was used to assess the translocation of the
peptide C-terminus into the liposome interior. The biotin moiety was linked to the Cterminal Cys of the peptides via a long polar polyethylene glycol (PEG) linker. The
linker has a double purpose. It facilitates biotin access to the avidin binding site and—
more critically for our experiments—helps to delineate between an intraliposomal
location and an extraliposomal location of the biotin, since the polarity of the moiety
makes a location inside the hydrophobic region of the bilayer unlikely. We quantified
the amount of biotin that binds to avidin molecules present exclusively outside the
liposomes (see Materials and Methods for details). We did not detect avidin binding to
biotin for the D2 peptide at low pH (Fig. 5a) due to the biotin translocation across the
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membrane, which complements our data (suggesting complete insertion of this peptide
across the lipid bilayer) and confirms that the directionality of insertion is the same as
for wt. Only partial translocation and no translocation of biotin across the membrane
were seen for D1 and D0, respectively (Fig. 5a), in agreement with our results
indicating partial (or tilted) insertion and no insertion into the lipid bilayer of D1 and
D0, respectively. Additionally, the translocation of biotin (which can be considered as
a cargo) across the membrane does not appear to significantly hinder the membrane
insertion of the peptides. This might be explained by its small size (526 Da) and its
moderate polarity (logP = − 1.4; see Materials and Methods for details), which are
both well within the range of cargo properties that pHLIP has been reported to
effectively translocate.21 However, as the biotin assay used here is responsive to
changes in the level of binding to avidin present outside of the liposomes, we cannot
rule out the possible influences of different processes such as peptide aggregation,
although we have no reason to suspect them.
How does the number of carboxyl groups affect the pK and cooperativity of insertion?
We monitored the pH-induced changes in the position of the fluorescence emission
maximum of the peptides, which provide details about peptide insertion into the lipid
bilayer, in the presence of POPC (Fig. 6). A plot of the positions of the spectral
maxima follows a sigmoid behavior as a function of pH, corresponding to the
transition between the interfacial state and the inserted state for all variants (except for
D0). Fitting the experimental data provides the two main parameters that describe the
insertion process: pKa and cooperativity (m). The pKa of membrane insertion obtained
for wt pHLIP is 5.94 ± 0.09, which is in agreement with previous reports. 1 and 7 For the
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different variants, shifts of the pKa to lower values (∼ 5.2) were detected (Fig. 7a).
The reason for this decrease is unclear, but it might be related to the lower number of
aspartic residues or to the presence of histidines in the TM region of the pHLIP
variants. We do not think that the N-terminal DDDED sequence will influence the pKa
values of the peptides in our study, since its polarity should preclude hydrophobic
interaction with the lipid bilayer; thus, it is not expected to be involved in the insertion
process. However, we cannot rule out that it might reduce the overall membrane
affinity of the peptide. While the pKa values for the variants changed very little, we
observed a gradual decrease in the cooperativity of the insertion process (m
parameter) for peptides with fewer Asp residues, as the titration occurred
progressively over a wider pH range (∼ 1 pH unit for wt and ∼ 2 pH units for D1)
(Figs. 6 and 7b). Our data indicate that the cooperativity of insertion is linked to the
number of protonatable residues. Cooperativity and pKa might also respond to the
position of protonatable groups in the peptide sequences and their proximity to each
other. When pHLIP is at the surface of the vesicle and the pH is lowered, the
protonation of one Asp residue might facilitate the protonation of other protonatable
residues, shifting their pKa values. The protonation of the first Asp residue might
induce partial insertion of the peptide into the membrane. In this scenario, the
protonation of the neighboring Asp residues would be energetically favored to shield
the negative charge (i.e., the pKa value of the neighboring Asp is shifted to higher
values in a more hydrophobic environment) and then a positive feedback would be
established, triggering membrane insertion.
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How do the number and the location of Asp residues affect peptide exit from the
membrane? The CD and fluorescence changes associated with wt pHLIP lipid
insertion at acidic pH are completely reversible.11 Here we also followed changes in
the CD and fluorescence signals and in the reversibility of biotin translocation across
the membrane. The ellipticity increase associated with each peptide insertion into the
membrane was found to be essentially reversible for wt and D3b (Fig. 3, broken blue
lines overlap with continuous blue lines), while for D3a, D2, and D1, the reversibility
was only partial. Since changes in the CD signal upon acidification for D2–D0 are less
pronounced than those for wt and D3, the reversibility of the D2–D0 membrane
insertion was also assessed by changes in the fluorescence signal (Fig. S4). It is
interesting to note the different levels of reversibility of the two D3 peptides: the
insertion process is significantly more reversible in D3b (90%) than in D3a (70%)
(Fig. 5b), suggesting nonequivalence of the two buried positions. We observed an
overall linear relationship between the number of aspartic acid residues interacting
with the membrane and the degree of α-helix formation reversibility (Fig. 5b). The
results obtained for the reversibility of the biotin translocation (exit process) were also
in agreement (Fig. 5b).
An important consideration in the interpretation of the exit data is the time course of
equilibration of the pH inside the liposomes, so we encapsulated the membraneimpermeable fluorescent probe 5(6)-carboxy-2′,7′-dichlorofluorescein in POPC
liposomes to follow the pH changes. The fluorescence of the probe is pH-sensitive,
with a pKa of 5.1. When we varied the pH of the solution outside the liposomes, the
fluorescence of the encapsulated probe changed in a sigmoid fashion, with an apparent
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pKa of 5.05 (data not shown). A relatively high proton permeation through unilamellar
POPC liposomes in the minute timescale has been reported elsewhere.

22 and 23

On the

other hand, our kinetic data suggest that the time of wt peptide exit (with two TM
groups and four C-terminal protonatable groups) is in the range of milliseconds.6
Thus, peptides exit from the lipid bilayer much faster such that the pH is completely
equilibrated inside the liposomes and, most probably, C-terminal residues cross the
membrane in their noncharged form. The question is: ‘Why is the reversibility of D3a,
D2, and, to some degree, D1 only partial?’ To provide an explanation, we take into
account the location of the Asp residues. For the peptide exit from the lipid bilayer to
take place, the deprotonation of Asp residues must energetically destabilize the
inserted state. Destabilization of the inserted state is mainly caused by the charges
resulting from the deprotonation of groups deeply buried in the hydrophobic core of
the membrane. Therefore, the exit of wt and D3b, which have two Asp or one Asp in
the hydrophobic core of the membrane, is fully reversible. The reason for the
difference in peptide insertion reversibility between D3a and D3b might be related to
the presence of an arginine residue at position 11. Accordingly, the deprotonation of
Asp25 in D3b would strongly destabilize the membrane-inserted state due to the
presence of a negative charge in the hydrophobic core of the membrane, favoring the
exit process. However, the negative charge of Asp14 in D3a might be forming a salt
bridge with the neighboring side chain of Arg11, which would result in a weaker
destabilization of the inserted state. Another potential explanation is an altered
position of the TM domain, which was mentioned above. There is a possibility that the
TM domain in variants is shifted toward the C-terminal residues, leading to a greater
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exposure of the amino acid in position 14 (with His in D3a) to the aqueous
environment and a shift to the hydrophobic core of amino acids at positions 31 and 33.
As a result, the deprotonation of His14 in D3a might be associated with less
destabilization of the helix than deprotonation of His25 in D3b. The side chains of
Asp31 and Asp33 most probably are interacting with the headgroup region of the
bilayer. The destabilization energy associated with their deprotonation is not enough
to cause a complete exit from the membrane. Our results suggest that the
deprotonation of acidic residues located in the hydrophobic core of the membrane
ensures complete exit of the peptide.
Discussion
We have previously observed that even conservative changes in the pHLIP sequence
can lead to peptide aggregation in solution at neutral pH.7 Our results show that all the
peptides in this study are soluble in solution, being essentially monomeric (the
addition of a D-tag at the N-terminus and the L26G mutation appear to favor peptide
solubility). Spectral data obtained with D3–D0 peptides indicate that the lower is the
number of negatively charged groups in the peptide sequence, the deeper are the
peptide partitions into a lipid bilayer and the greater is the helicity. At the same time,
TM orientation (at least for the D3–D2 peptides) requires protonation of the Asp/Glu
residues and the terminal carboxyl group at the C-terminus, which can readily go
across a membrane in its noncharged form. We confirmed our previous finding2
suggesting that TM Asp residues are not essential for peptide insertion. Interestingly,
we have observed here that membrane insertion upon acidification occurs in our
peptides in the presence of two His residues in the predicted TM region. Histidines
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have been used in the past to drive the insertion of peptides into membranes at neutral
pH values.17 and 18 However, in these examples, acidic residues were completely absent
in the sequence. For the peptides described in this article, the establishment of states II
and III is driven by acidic residues. Since the protonated (charged) state of the side
chains of His14 and His25 in the hydrophobic core of the membrane would be
energetically very unfavorable, in the peptides, their pKa values are expected to shift to
lower values in the membrane-inserted state (favoring the unprotonated state). Further
acidification eventually causes their protonation, resulting in a strong destabilization
of the inserted TM helix and peptide exit. We cannot rule out that the diminished
membrane insertion of the D1 and D0 peptides might be influenced by the
hydrophobicity change concomitant to the Asp-to-Asn mutations at the C-terminus.
The free energy of membrane transfer of the Asn side chain is 0.42 kcal/mol, which is
a less favorable value than the free energy of transfer of the neutral state of Asp
(− 0.07 kcal/mol)5; thus, the membrane translocation of the C-terminus would be less
favorable. A similar effect might occur in the insertion reversibility of D1.
We conclude that protonation of negatively charged residues located in the TM or in
the C-terminal inserting end must occur in order to preserve the pH-dependent ability
of pHLIP to interact with the membrane. These residues act as switches for pHLIP
membrane insertion, as the negative charges of their side chains block membrane
insertion. Acidification causes the protonation of these side chains, resulting in an
increase in the overall hydrophobicity of the peptide, which leads to TM helix
formation, shielding the hydrophobic residues of pHLIP from water molecules. When
the pH is raised to near neutrality, the negatively charged state of the carboxyl groups
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is again favored, decreasing the peptide hydrophobicity and resulting in exit from the
TM position. Peptide exit from the lipid bilayer is completed when deprotonation of
Asp/Glu residues located in the hydrophobic core of the membrane occurs and the TM
helix is destabilized.
The knowledge gained from our experiments can be used as a guide to improve the
imaging and therapeutic properties of pHLIP. For the specific case of tumor targeting,
the pHLIP insertion characteristics should be finely tuned to exploit the low
extracellular pH (pHe) of tumors. Tumor targeting by wt pHLIP conjugated to a Cu64–
1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid chelate for positron emission
tomography imaging correlates with the pHe of tumors, where the contrast index was
higher for LNCaP tumors (pHe 6.78 ± 0.29) than for PC-3 tumors (pHe 7.23 ± 0.1024).
Thus, pHLIP variants where Asp14/Asp25 were replaced by Glu, with a higher pKa
(pKa = 6.5),7 might be more effective for targeting tumors with higher pHe values. Our
present results suggest that the number of Asp residues in the TM region can also
modulate the pKa value. Thus, a peptide containing an extra Asp in the TM region
might have a higher pKa and might be directed to tumors more effectively. Another
important factor to be considered is the broadness of the pH transition of the peptide,
which is dictated by the cooperativity of the transition. On one hand, for the case
where the peptide pKa is lower than the tumor pHe but the transition is broad (m value
is low), a significant part of the pH transition could intercept the pH e value, resulting
in a significant pHLIP tumor insertion. However, such a scenario will also lead to
more accumulation in healthy tissue. Since it is usually desirable to have a high
tumor/organ ratio, an insertion transition of high cooperativity might be best. This
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would ensure greater differentiation between the amount of inserted peptides and the
amount of noninserted peptides over a narrow range of pH values, favoring selective
tumor targeting, since the difference in pH between normal tissue and cancerous tissue
may be only 0.5–0.7 units. However, we must bear in mind that the measured pHe
provides an indication of the average acidity outside the cell for a given tumor and can
vary between different tumor regions. Furthermore, pHe may not reflect the precise pH
on the exterior surface of the cells, since the cells pump protons to the extracellular
medium and ΔpH will lead to proton accumulation at the membrane surface.25
Another feature that is expected to shift the equilibrium toward the membrane-inserted
form is the presence of Asp/Glu residues at the C-terminus of the peptide. After being
translocated across the plasma membrane into the cytoplasm, where the pH is neutral,
these groups would be deprotonated. Since the translocation of charges across
membranes is unfavorable, the inserted form would be stabilized.
pHLIP shows promise as a means of targeting cells in acidic tissues and delivering
agents for therapy and imaging. At the same time, we are learning more about the
binding and insertion of peptides at the membrane surface. Here we have shown that
variation in the positions and numbers of carboxyl group titrations modulates the pK
and cooperativity of insertion.
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Materials and methods
Peptide synthesis and assessment of monomeric state
Peptides

were

made

by

solid-phase

synthesis,

using

standard

9-

fluorenylmethyloxycarbonyl chemistry, at the W. M. Keck Foundation Biotechnology
Resource at Yale University (New Haven, CT) and were purified by reverse-phase
chromatography (C18 column, using a water/acetonitrile gradient in 0.01%
trifluoroacetic acid). Purity was checked by matrix-assisted laser desorption/ionization
time-of-flight

mass spectrometry. Peptides

were quantified by absorbance

spectroscopy using a molar extinction coefficient of 13,940 M− 1 cm− 1. Some peptides
contain a single Cys residue in the C-terminus and thus have the potential to form
intermolecular disulfide bonds, leading to the formation of dimers. To rule out the
possibility that this might occur under our experimental conditions, we ran HPLC on
peptide samples incubated (at room temperature for 3 h) at concentrations higher than
those used in our experiments and in the absence and in the presence of POPC. No
dimer band could be detected, and concentrations in the range of 0.1 mM peptide and
overnight incubation were required to detect a significant amount of dimer (∼ 10%).
The peptides described in Table 1 were used in the experiments, except for some
experiments with D2–D0, where a Cys-less version was employed (similar results
were obtained for both results; data not shown).
Analytical ultracentrifugation
Sedimentation velocity experiments were performed at 25 °C in a Beckman Optima
XL-I analytical centrifuge at 35,000 rpm. Peptides at a concentration of 7 μM were
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dissolved in 5 mM phosphate buffer (pH 8) after 1 h of incubation at room
temperature. Absorbance at 280 nm was used to monitor centrifugation, and analysis
was performed using SEDFIT.26
Liposome preparation
The required amount of chloroform-dissolved POPC (Avanti Polar Lipids) was placed
in a glass tube, dried with argon, and then held under vacuum overnight. The dried
film was resuspended in water or 10 mM phosphate buffer (pH 8) and vortexed.
Extrusion to make unilamellar vesicles was performed using a Mini-Extruder (Avanti
Polar Lipids), with Nuclepore polycarbonate membranes of 0.1 or 0.05 μm pore size
(Whatman). To obtain the final large unilamellar vesicles, we performed 15–25
extrusion steps, depending on the lipid concentration.
Fluorescence spectroscopy
Peptides were dissolved in 5 or 10 mM phosphate buffer (pH 8) and incubated with
POPC vesicles prepared in water, resulting in a molar lipid/peptide ratio of 250:1. The
incubation time with POPC liposomes varied from 90 min to 18 h. The pH of the
samples was adjusted with a 10 mM concentration of the buffers for the indicated pH
ranges (H3PO4, pH 1.0–3.5; sodium acetate, pH 3.5–5.5; Na2HPO4/NaH2PO4, pH 5.5–
8.0; sodium borate, pH 8.0–10.5) or by addition of concentrated HCl. The final
peptide concentration was varied from 1.5 to 5 μM in different experiments. Emission
spectra were measured in SLM-Aminco 8000C and PC2 ISS spectrofluorometers at
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room temperature (controlled temperature), with excitation at 295 nm. The appropriate
blanks were subtracted in all cases.
For determination of spectral maxima, we used the FCAT mode of the PFAST
software, which fits the experimental spectra to log-normal components.27 and 28 The
spectral maxima values for each point of the pH curve were plotted and analyzed
according to29:

F

F

 Fb 10 m ( pH  pKa)
(1  10 m ( pH  pKa) )
a



Equation(1)

where Fa = (fA + SApH) and Fb = (fB + SBpH); fA and fB are the spectral maxima for the
acidic and basic forms, respectively; SA and SB are the slopes of the acidic and basic
baselines, respectively; and m is the cooperativity parameter. Fitting by nonlinear least
squares analysis was carried out with Origin software.
Circular dichroism
Samples were prepared as in the fluorescence experiments, but the final molar
lipid/peptide ratio was 300:1, with the final peptide concentration varying from 2 to
5 μM. CD spectra were recorded in Jasco J-810 and MOS450 Biologic
spectropolarimeters interfaced with a Peltier system. Spectra were recorded at 25 °C
using 2- or 5-mm cuvettes, the scan rate was 50 nm/min, and 10–30 averaging steps
were performed. Raw data were converted into mean residue ellipticity according to30:
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[Θ]=Θ/(10lcN)
where Θ is the measured ellipticity, l is the path length of the cell, c is the protein
concentration, and N is the number of amino acids.
For the study of membrane attachment, insertion, and its reversibility, the typical
procedure was as follows: The samples were incubated with POPC vesicles at pH 8
for 90 min, the spectra were recorded, the pH was lowered to 4.0, and the
measurements were performed after 30 min. Finally, the pH of the sample was
increased with sodium borate buffer (pH 10.2) to a final pH of 7.5. After 30 min,
90 min, and 24 h, the spectra were recorded, and similar results were obtained in all
cases. The degree of reversibility was established from the recovery of the signal at
222 nm. The final buffer concentration for the different experiments was in the range
of 3–15 mM. Appropriate blanks were subtracted in all cases.
OCD measurements
For OCD measurements, supported bilayers were prepared on quartz slides with 0.2mm-thick spacers on one side and with a special polish for far-UV measurements
(Starna). Slides were cleaned by sonication for 10 min in cuvette cleaner solution
(Decon Contrad 70, 5% in water), 2-propanol, acetone, and 2-propanol, and rinsed
with deionized water. Then the slides were immersed in a mixture of concentrated
sulfuric acid and hydrogen peroxide (3:1) for 5–10 min to completely remove any
remaining organic material from the slides. The slides were then thoroughly rinsed
with and stored in deionized water (Milli-Q purified water kept at 25 °C). A POPC
lipid monolayer was deposited on a quartz substrate by the Langmuir–Blodgett
57

method using a KSV mini-trough. For the Langmuir–Blodgett deposition, a cleaned
slide was vertically immersed in the clean subphase (Milli-Q purified water kept at
25 °C) of a Langmuir–Blodgett trough. A POPC lipid solution in chloroform was
spread on the subphase, and chloroform was allowed to evaporate for about 30 min,
followed by monolayer compression to 32 mN/m. The first layer was deposited by
retrieving the slide from the subphase at a rate of 15 mm/min. The second layer of the
bilayer was created by fusion. For this step, the monolayer on the slide was incubated
with a solution of POPC vesicles (50 nm in diameter, obtained by extrusion) mixed
with peptide solution at the required pH (0.5 mM POPC and 10 μM peptide). The
fusion occurred for about 6 h under 100% humidity. Then, excess vesicles were
carefully removed, and the slides were stacked to make a pile while filling up the
spaces between them with a peptide solution (5 μM) at the required pH. The bilayers
with the peptide solution were allowed to equilibrate for about 6 h. Measurements
were taken in three steps during the process: when the monolayers were incubated
with an excess of liposomes, soon after the spaces between the bilayers had been filled
with the peptide solution and 6 h after the second measurement. Fourteen slides (28
bilayers) were assembled, and the OCD spectrum was recorded on a MOS-450
spectrometer at a sampling time of 2 s.
Biotin translocation assay
HABA dye (4′-hydroxyazobenzene-2-carboxylic acid) binds to avidin at a 1:1
stoichiometry and absorbs at 510 nm only in the avidin-bound state. This interaction is
strongly displaced by the binding of biotin to avidin, resulting in a quantitative
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reduction in HABA absorbance. This property was used to probe the location of the Cterminus of different peptides with regard to the liposome (inside or outside) (method
modified from Nicol et al.31). The C-terminus of each of the peptide variants was
labeled with biotin (see the text below). The rationale for the assay is that pH-driven
insertion of the C-terminus would result in biotin translocation inside the liposome,
causing shielding of the biotin from the medium outside the liposome, where a
preformed HABA/avidin complex (Thermo Scientific) is added. If the biotin is inside
the liposome, no change in absorbance is expected. On the other hand, if pHLIP lies at
the exterior surface of the liposome, the C-terminal biotin would be accessible to the
solution outside the liposome (as the biotin group is polar, it is expected not to be
protected by the membrane) and would be able to bind to avidin and displace the
HABA/avidin complex, with a consequent reduction in absorbance at 510 nm.
Liposomes were prepared in 150 mM NaCl, and ionic strength was carefully
maintained during all steps to avoid liposome osmotic shock. Biotin-labeled peptides
were incubated in the presence of POPC at pH 8 for 2 h at room temperature (150:1
lipid/peptide ratio). For studies of C-terminal translocation, acetate buffer was added
to the samples, resulting in a final pH of 4.3 prior to 1 h of incubation with the
peptide. The HABA/avidin complex was added to the solution only after the final
conditions had been established. The final peptide concentration for the measurement
conditions was 3 μM. To determine the reversibility of the biotin translocation, we
increased the pH by the addition of 10 mM sodium borate buffer (pH 10.2) to give a
final pH of 7.4. Absorbance was measured after 1 h of incubation. For quantitation of
the level of reversibility, the recovery of absorbance obtained for pHLIP labeled with
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biotin at its C-terminus was taken as 100% reversibility, and that of pHLIP labeled at
its N-terminus was taken as 0%.
Peptides were labeled at the C-terminal Cys residues using the membraneimpermeable compound maleimide–PEG2–biotin (Thermo Scientific), which has a
long polar spacer arm of 29.1 Å to allow adequate biotin binding to avidin. The
synthesis reaction was performed in 10 mM phosphate buffer (pH 7.5; overnight
incubation at 4 °C). Reaction products were purified by HPLC, and the mass of the
biotin-labeled peptides was checked by matrix-assisted laser desorption/ionization
time-of-flight mass spectrometry. The octanol/water partition coefficient of
maleimide–PEG2–biotin was determined experimentally by measuring the absorbance
at 300 nm in the aqueous and octanol (previously preequilibrated with water) phases
after 2 h of vortexing. A logP value of − 1.07 ± 0.02 was obtained. As this value does
not take into account the chemical changes in the cross-linking reaction (formation of
a thioether bond between the maleimide moiety and the Cys side chain), the QikProp
3.0 software was employed to predict the logP value of the reacted form, resulting in a
value of − 1.4, which is in the range of molecules that can be translocated by pHLIP.21
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Tables

Table 1. Sequence of the peptides.
wta
D3ab
D3b
D2c
D1c
D0c

AAEQNPIYWARYADWLFTTPLLLLDLALLVDADEGTCG
DDDEDNPIYWARYADWLFTTPLLLLHGALLVDADECT
DDDEDNPIYWARYAHWLFTTPLLLLDGALLVDADECT
DDDEDNPIYWARYAHWLFTTPLLLLHGALLVDADECT
DDDEDNPIYWARYAHWLFTTPLLLLHGALLVNADECT
DDDEDNPIYWARYAHWLFTTPLLLLHGALLVNANECT
14

a
b

25

31 33

The pHLIP sequence is referred to as wt.
The variant peptides are named by a D followed by the number of aspartic acid

residues in the TM and C-terminal regions. Two different D3 peptides were studied,
D3a and D3b, each with different transmembrane aspartic acid residues mutated. The
acidic residues that are expected to interact with the hydrophobic core of the
membrane at some stage of the insertion process (Asp 14, 25, 31 and 33, in red) were
mutated to the polar residues marked in bold. The N-terminal Asp-tag and the
Leu26Gly mutation are highlighted in italics. The transmembrane region of pHLIP
was predicted, using the octanol scale5, to be located between residues Ile7 and Leu29
(marked with inverted blue triangles). N- and C-terminus were not capped.
c

A version of D2-D0 without cysteine were employed in experiments except of biotin

translocation assay.
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Table 2. Parameters describing the studied peptides.
AUC a
Sed.
Coef.
State
I
wt
D3a
D3b
D2
D1
D0

0.80±0.17b
0.67±0.08
0.66±0.09
0.84±0.16
0.88±0.18
0.75±0.20

Fluorescence
Spectral maximum, nm

I

State
II

III

347.7±0.6
349.9±0.1
349.1±1.0
348.2±0.1
346.2±3.6
347.2±1.0

347.2±1.6
347.4±1.3
345.5±0.7
344.9±1.4
343.7±1.6
341.0±0.6

336.7±0.1
337.0±0.1
334.6±0.2
336.5±0.7
337.4±1.0
338.0±0.9

Circular
Dichroism
Area
curve
State
II
III
1.04
1.12
1.08
1.09
1.10
1.71

2.10
2.61
2.11
1.53
1.46
1.21

MRE 218 nm

I
-7.4
-7.6
-5.3
-7.9
-7.0
-6.5

State
II
III
-7.4
-6.8
-6.1
-9.3
-10.5
-13.5

-16.3
-15.4
-16.4
-14.1
-15.6
-12.8

a

The sedimentation coefficient for the peak corresponding to the monomer is showed.

b

The averages and the standard deviations are provided.

c

The spectral maxima were calculated with PFAST (see Methods).
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Figures

Figure 1. Sedimentation velocity of the different peptide variants. Apparent
sedimentation coefficient distribution derived from sedimentation velocity profiles of
the peptides(7 µM)) in 5 mM phosphate buffer at pH 8.
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Figure 2. Fluorescence spectra of peptides in buffer and with POPC vesicles.
Emission spectra of each variant were recorded under the following conditions: buffer
at pH 7.5 (black lines), POPC at neutral pH (blue lines), and POPC at pH 4 (red lines).
The pH values for the different POPC samples at neutral pH were selected according
to the midpoint and slope of the transitions shown in Figure 6: wt, pH 7.5; D3a,
pH 7.5; D3b, pH 7.1; D2, pH 6.5; D1, pH 6.2; D0, pH 8. The peptide concentration
was 1.5 μM, and the lipid concentration was 375 μM. Fluorescence intensity is given
in arbitrary units (AU).
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Figure 3. CD of peptides in buffer and with POPC vesicles. Far-UV CD spectra
were recorded for all variants under different conditions: buffer at pH 7.5 (black lines),
POPC at pH 7.4 (blue lines), and POPC at pH 4 (red lines). The reversibility of the
insertion process was studied by raising the pH of the samples from pH 4 (broken blue
line) to pH 7.4. Reversibility for D0 was not studied, as the ellipticity changes between
the states at pH 7.5 and pH 4 were negligible. In all samples, the final peptide and
lipid concentrations were 5 μM and 1.5 mM, respectively.
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Figure 4. OCD spectra of D2, D1, and D0 measured on oriented POPC-supported
bilayers at neutral (blue lines) and acidic (red lines) pH values. The OCD spectrum
of D2 at pH 1.9 was also recorded (purple line). The experimental spectra are
corrected for the lipid background.
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Figure 5. Quantification of membrane insertion (biotin translocation) and
reversibility. Data corresponding to the biotin translocation assay (open squares) and
CD (black symbols) were plotted against the number of Asp residues in the TM and Cterminal regions. (a) Degree of normalized biotin translocation (open squares). For
data normalization, the translocation levels of wt pHLIP labeled with biotin at the Cterminus and N-terminus were used as 100% and 0%, respectively. Results from D3a
and D3b are not shown for the biotin translocation assay, as the biotin labeling for
these peptides affected the interaction with lipids (data not shown). No adverse effects
of labeling were observed for the rest of the peptides tested. Averages and standard
deviations are shown. (b) The percent reversibility of the biotin translocation of the
samples used in (a) is shown (open squares). For CD experiments (Fig. 3), the degree
of reversibility was determined by monitoring the relative changes in ellipticity at
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222 nm (black symbols). Averages and standard deviations are shown. Data
corresponding to D3b appear as a triangle, while the rest of the CD data appear as
circles. All data points were used for linear fitting (R2 = 0.95).
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Figure 6. Fluorescence spectral maximum changes upon pH titration. The pHcontrolled transitions of the peptides in POPC were followed by monitoring the
variations in the spectral maxima. The experimental data for the different peptides
were fitted to Eq. (1) (black lines). Representative experiments are shown.
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Figure 7. Parameters obtained from the fitting of fluorescence pH transitions.
The pKa (a) and m parameter (b) values obtained from the fitting of the data in Figure
6 to Eq. (1) are shown in black symbols. Data from the D3b variant are shown as
triangles (to maintain the representation as in Fig. 5). The line corresponds to the
fitting of all data points (R2 = 0.93). Averages and standard deviations are shown.
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Supplementary information
Roles of carboxyl groups in the transmembrane insertion of peptides.
Francisco N. Barrera, Dhammika Weerakkody, Michael Anderson, Oleg A. Andreev,
Yana K. Reshetnyak and Donald M. Engelman

Figure S1. Fluorescence of D2 in presence of POPC at various pH values.
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Figure S2. Leakage of encapsulated calcein. The release of calcein encapsulated in
large unilamellar POPC liposomes was measured by following the fluorescence at 515
nm in the presence of different concentrations of peptides. Little disruption by peptide
interaction is seen. The level of 100% disruption of liposomes was determined by
addition of 0.05% Triton X-100
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Figure S3.

Fluorescence of wt and D2 at low pHs. The usual range of pHs was

extended to lower values to study the protonation state of His residues. D2 was
employed as an example of peptide containing two His residues. Upper panels:
Emission spectra in POPC liposomes at pH 2.2, 3.3 and 6.3. Lower panels: the
fluorescence intensity and center of mass were calculated for the complete pH range
studied for D2 and wt pHLIP.
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Figure S4.

Fluorescence studies of the reversibility of the membrane insertion

for D2, D1 and D0. Spectra were measured of the peptides in the presence of POPC at
pH 4.1 (red lines) and 7.8 (straight blue lines). The pH of the samples at pH 4.1 was
increased back to 7.8 (dashed blue lines) to study reversibility. For D2, where
acidification caused TM helix formation occurs, the two blue lines have a good
overlap, suggesting a high degree of reversibility. For D1 and D0, a TM helix is not
formed in a pH-dependent fashion, so the interpretation of the reversibility data is less
straightforward.
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Abstract
The membrane-associated folding/unfolding of pHLIP (pH (Low) Insertion Peptide)
provides an opportunity to study how sequence variations influence the kinetics and
pathway of peptide insertion into bilayers. Here we present the results of steady-state
and kinetics investigations of several pHLIP variants with different numbers of
charged residues, with attached polar cargoes at the peptide’s membrane inserting end,
and with three single-Trp variants placed at the beginning, middle and end of the
transmembrane helix. Each pHLIP variant exhibits a pH-dependent interaction with a
lipid bilayer. While the number of protonatable residues at the inserting end does not
affect the ultimate formation of helical structure across a membrane, it correlates with
the time for peptide insertion, the number of intermediate states on the folding
pathway, and the rates of unfolding and exit. The presence of polar cargoes at the
peptide’s inserting end leads to the appearance of intermediate states on the insertion
pathway. Cargo polarity correlates with a decrease of the insertion rate. We conclude
that the existence of intermediate states on the folding and unfolding pathways are not
mandatory and, in the simple case of a polypeptide with a non-charged and non-polar
inserting end, the folding and unfolding appears as an all-or-none transition. A model
for membrane-associated insertion/folding and exit/unfolding is proposed, and the
importance of these observations for the design of new delivery agents for the direct
translocation of polar therapeutic and diagnostic cargo molecules across cellular
membranes is discussed.
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Introduction
The molecular mechanism of spontaneous polypeptide folding and insertion into a
membrane as well as its exit and unfolding is of interest from several standpoints,
including the action of antimicrobial peptides, the folding and degradation of
membrane proteins, and the medical applications of the pH triggered insertion
peptides. Most helical membrane proteins insert into a lipid bilayer with the assistance
of the translocon machinery (1, 2). While they are assisted in their pathways by the
Get proteins (3), tail-anchored membrane proteins can spontaneously insert and fold
themselves across the lipid bilayer of a membrane, and may do so when released by
the Get complex in vivo (4, 5). The stability and folding of membrane proteins are
strongly constrained by the formation of secondary structures in the lipid bilayer
environment, driven by the hydrophobic effect and hydrogen bonding (6-8). When
helical membrane proteins are degraded, their TMs must exit the bilayer as they
become destabilized by cleavages (9). Peptide insertion into a bilayer can be triggered
by a pH jump if it leads to the protonation/de-protonation of charged groups to render
them uncharged and so to increase peptide hydrophobicity and affinity for the
nonpolar region of a membrane. One example of a synthetic peptide with pH
dependent membrane-insertion properties has been investigated by White and
Ladokhin (10). Another example, which is the subject of this study, is the pH Low
Insertion Peptide (pHLIP) family. At neutral and high pHs, pHLIP is monomeric and
largely unstructured, and equilibrates between aqueous solution and the surface of a
lipid bilayer. Lowering the pH shifts the equilibrium towards transmembrane insertion
and the formation of a TM helix (11). A subsequent increase of pH promotes
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unfolding of the TM and exit from the bilayer. The process of binding of the peptide to
the membrane surface is accompanied by an energy release of 6-7 kcal/mol and the
process of insertion is accompanied by an additional energy release of about 1.8-2.0
kcal/mol (12). We previously showed that pHLIP insertion is associated with the
protonation of Asp/Glu residues, which leads to an increase of hydrophobicity that
triggers the folding and insertion of the peptide across a lipid bilayer (13, 14). The
insertion of the pHLIP is unidirectional: the C-terminus crosses the lipid bilayer, and
the N-terminus stays outside (11, 15). The energy of membrane associated-folding can
be used to favor the movement of cell-impermeable polar cargo molecules across the
hydrophobic membrane bilayer when they are attached to the inserting end of pHLIP
(15-17). Both pH-targeting behavior and molecular translocation have been
demonstrated in cultured cells and in vivo (16-21). Thus, there is an opportunity to
develop a novel concept in drug delivery, which is based on the use of a monomeric,
pH-sensitive peptide molecular transporter to deliver agents that are significantly more
polar than conventional drugs.
In our initial kinetic study we found that pHLIP inserts into a POPC phospholipid
bilayer in several steps: first, an interfacial helix is rapidly formed (~100 ms), which is
then followed by a slow transmembrane insertion pathway (~1 minute) that contains
several intermediates. The exit of the peptide from the bilayer core proceeds ~800
times faster and through different intermediates (22). It remained unclear why it takes
1000 times longer for the helix to insert across a bilayer after it is formed on the
surface, and what the intermediates are on the insertion/exit pathways. Another
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question we wanted to address is how polar cargo might affect the process of insertion,
and thus, translocation of cargo across the bilayer.
Materials and methods
Due to the limit of space, a detailed description of experiments could be found “in the
Supporting Material”.
Results
Design of pHLIP variants
Our previous data indicated that the pHLIP peptide forms a helix, after a pH drop,
1000 times faster than it inserts into a lipid bilayer, and insertion occurs through
several steps. The insertion time and nature of the intermediates might result from the
presence of four protonatable groups at the C-terminus of the peptide, which have to
cross the membrane to complete the process of insertion. In order to cross the energy
barrier presented by the hydrophobic membrane core at any appreciable rate, it is
reasonable to hypothesize that these charged groups should be at least partially
protonated. To test the idea, we asked if the number of protonatable groups at the Cterminus would correlate with the rates of insertion and exit, as well as examining the
number of intermediate states along the insertion/exit pathways. Two truncated pHLIP
variants were designed: pHLIP-2 and pHLIP-1, where the number of protonatable
groups (shown below in red) was reduced to two and one, respectively. Additional
Asp residues were placed at the N-terminus to preserve peptide solubility.
pHLIP-4:

AE-QN-PI YWARYADWLFTTPLLLLDLALLV DADEGTCOOH

pHLIP-2:

AEDQN-P- YWARYADWLFTTPLLLLDLALLV D---G-COOH

pHLIP-1:

AEDQNDP- YWARYADWLFTTPLLLLDLALLV ----G-COOH
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To gain insights into the structural nature of the intermediates along the insertion and
exit pathways, we studied three single-Trp variants of pHLIP-4 peptide (pHLIP-W1,
pHLIP-W2 and pHLIP-W3), where a Trp residue was positioned at the beginning,
middle, and end of the TM helix.
pHLIP-W1:

AEQNPI

YWARYADFLFTTPLLLLDLALLV DADET-COOH

pHLIP-W2:

AEQNPI

YFARYADWLFTTPLLLLDLALLV DADET-COOH

pHLIP-W3:

AEQNPI

YFARYADFLFTTPLLLLDLALLW DADET-COOH

The following pHLIP sequences were selected for the conjugation of polar cargoes to
the inserting end to probe cargo effects on kinetics:
pHLIP-4:

AE-QN-PI YWARYADWLFTTPLLLLDLALLV

DADEGCTCOOH

pHLIP-2:

AEDQN-PI YWARYADWLFTTPLLLLDLALLV

D---GCTCOOH

pHLIP-2E:

AEDQNDPI YWARYADWLFTTPLLLLELALLV

E---GCTCOOH

pHLIP-2E is a pHLIP-2 where the two Asp residues are replaced by Glu to increase
the pKa of peptide insertion, which is desirable for the translocation of polar cargo
into cytoplasm. Each of the last three pHLIP variants had a free SH group at its Cterminus for conjugation with maleimide-cargo. As cargo we chose biotin and biotinPeg mainly based on their Log P values (chosen to be slightly polar), the convenience
of conjugation to the peptides, the low level of absorbance, and the absence of
fluorescence in the UV range (in contrast to fluorescent dyes and phallatoxins). The
measured Log P of biotin-maleimide and biotin-Peg-maleimide are -0.3 and -1.4,
respectively (for comparison, the Log Ps of phalloidin-rhodamine and phalloidin are 0.05 and -1.5, respectively (16). Information about Log P measurements can be found
in the supporting material. We have shown previously that the pHLIP-4 is capable of
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translocating biotin-Peg (23). All constructs were purified to remove unreacted peptide
and cargo.
Steady-state study of pHLIP variants
We employed fluorescence and CD/OCD spectroscopic techniques to demonstrate that
pHLIP variants and their cargo conjugates preserve pH dependent membrane-inserting
properties (Fig. S1-4). The data clearly indicate that all peptides preserve ability to
interact with lipid bilayer of membrane in a pH-dependent manner. The data also
suggest that the peptides may be partly pulled away from the membrane core by the
polar cargo molecules attached to their C-termini (especially pHLIP-2 and pHLIP-2E,
which are more hydrophobic and partition more deeply into the membrane and have
higher helix content at pH8 compared to pHLIP-4) (Fig. S3 and Table S1). Because
we had moved protonatable residues from the C to the N-terminus and attached polar
(non-charged) cargo, we checked for effects on the pH-dependencies of the insertion
(Fig. 1c, f and 4S). The perturbation of the insertion pKa by truncation of the Cterminus and attachment of the polar cargoes is small.
Mathematical models for fitting of kinetics data
In our earlier kinetic studies, we used a sequential mathematical model to fit the
kinetic data and to find the rates and contributions of individual components (22). To
simplify the mathematical model, only forward reactions were taken into
consideration. In the present work we have made an attempt to describe the processes
by taking into account both forward and backward reactions. We have considered
several linear models: two-state (no intermediates):
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three-state (single intermediate):

and four-state (two intermediates) models:

The transitions between states are described by a set of differential equations
(Appendix S1-3), which can be solved, but the functions obtained are very complex
and will contain a number of variable parameters increasing with the complexity of the
applied model. It is not practical to perform fitting of the experimental data using such
complex functions: a slight variation in input data dramatically affects the solution,
thus making it unreliable. However, the solution for fluorescence varation with time
can be presented in a general form as a sum of the exponential functions:

( )

(

⁄ )

( )

(

⁄ )

( )

(

⁄ )

for the (II) model (1)
⁄ )

(
(

⁄ )

where τi are the characteristic times

for the (III) model (2)
(

⁄ )

for the (IV) model (3)

for each transition or νi = 1/τi are the

characteristic rates of the transitions, and fi are the characteristic contributions. Thus
fitting of the measured curves can be performed using exponential functions and the
characteristic rate constants νi can be found directly from the experiment. However,
we wish to emphasize that the characteristic rates (or times) and contributions need to
be related to the rate constants (ki) and contributions for the transition from one
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intermediate to another, which fully reflect the transitions. Due to the complexity of
the problem, we proposed to establish relations only between the characteristic rates
and the real rate constants without considering the contributions. By making a few
reasonable assumptions, simple approximate relations between k and ν can be
established. Thus, for the two-state model (see Appendix S1):
(4)
for the three-state model (see Appendix S2):
,

(5)

and for the four-state model (see Appendix S3):
,

,

(6)

The experimental kinetic data were fitted by the single, or double, or triple exponential
functions (eqs. 1-3), which are general solutions for the two-, three- or four-state
models, respectively.
Kinetics of insertion of pHLIP variants with truncated C-terminus at various
temperatures
The insertion of each of the pHLIP-4, -2, -1 peptides into a lipid bilayer was triggered
by a drop of pH from 8 to 3.6 and was monitored at various temperatures (7, 11, 18,
25ºC) by the increase of tryptophan fluorescence (Fig. 1 a-c). The pHLIP-4 peptide
inserts across the bilayer as a helix within 30-50 sec (at various temperatures), the
pHLIP-2 – within 3-8 sec, and for the pHLIP-1 the process is completed in 80-400 ms,
which is about the same as the time of helix formation (90-100 ms) (Table 1). Thus the
processes of helix formation and insertion occur practically simultaneously in the
absence of protonatable side chains at the C terminal tail, and the number of
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protonatable residues at the inserting end does not affect the formation of helical
structure, but correlates with the time of peptide insertion into the lipid bilayer.
To ensure that the addition of Asp residues to the N-terminus of truncated pHLIP
variants does not alter the kinetics, we tested the following sequence:
pHLIP-6:

AEDQNDPIYWARYADWLFTTPLLLLDLALLVDADEGTCOOH

where an additional two Asp residues (total 6 Asp) were placed at the N-terminus of
pHLIP-4. The steady-state and kinetics data obtained for pHLIP-6 were very similar to
the data obtained with pHLIP-4 (Fig. S5), which confirms our suggestion that the
modification of the N-terminus does not interfere with the process of insertion.
Activation energies of pHLIP variants insertion into bilayer
Arrhenius plots were constructed to establish activation energies (Ea) and frequency
factors (A) for the transitions between the states for each pHLIP variant (Fig. 1d). The
points were fitted by the Arrhenius equation:
⁄

(7)

A global fit was used in the analysis of the second transition for pHLIP-2 and -1, and
for the second and third transitions for pHLIP-4, since slopes of the corresponding
curves are very similar to each other (established by separate fitting of each data set).
In the global fitting we used activation energy as a shared parameter to establish
differences in the frequency factors for various transitions. The activation energy
barrier for the pHLIP-1 and -2 is 13.2 kcal/mol. The frequency factor for the pHLIP-1
transition to the final state is 4.2x1010, which is an order of magnitude higher than the
frequency factor for the pHLIP-2 (1.9x109): we reason that this finding may reflect the
lower probability of simultaneous protonation of both COO- groups of Glu and Cterminus on the pHLIP-2, relative to the probability of protonation of the single
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carboxyl terminus of pHLIP-1. Insertion of the helical structure of the pHLIP-4 into
the lipid bilayer occurs in two steps, with an activation barrier of about 4.6 kcal/mol
each (9.2 kcal/mol combined), but with frequency factors (1.1x103 for
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transition) more than a million times lower than for the pHLIP-2 and -1. An especially
low frequency factor of 80 (for the transition of CD) was obtained for the transition
to the final TM state for the pHLIP-4.
Kinetics of insertion of pHLIP variants with cargoes
The attachment of biotin or biotinPeg cargoes to the peptides slows down the process
of insertion. The overall insertion time of the pHLIP-4 increases from 30-35 sec to 400
sec and 500 sec, when the biotin and the biotin-Peg are attached to the inserting end,
respectively (Fig. 2, Table 2). For the pHLIP-2 and pHLIP-2E the processes of
insertion slows down from 1-2 sec to 100-200 sec, and from 0.2 sec to 80-90 sec,
respectively. At the same time, the first (fast) rate of the insertion is very similar for all
pHLIP variants with and without cargo, and coincides with the rate of helix formation.
The higher the polarity of cargo attached to the inserting end, the slower the final steps
to adopt TM orientation and “flip” cargo across a membrane. It is interesting to note
that the biggest change of the fluorescence signal for pHLIP-4 is observed for the
peptide with no cargo. The steady-state measurements (Fig. S3) indicate that state II
(membrane-bound) is not affected significantly by the attachment of cargoes. At the
same time, when cargoes are attached, fewer pHLIP-4 peptides are reaching state III
(TM orientation), and smaller changes of fluorescence signal are observed. In contrast
to pHLIP-4, in the cases of pHLIP-2 and especially pHLIP-2E, the increase of
fluorescence is higher for peptides with the cargo compared to the peptides with no
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cargo. Truncated pHLIP-2s partition more deeply into the membrane and exhibit
formation of elements of secondary structure already in the state II, which is reflected
by the shift of the position of maximum and increase in emission (Table S1). The
cargo “pulls” the peptides to the membrane surface, affecting their state II positions.
Thus pHLIP-2 and pHLIP-2E with cargoes start their journey into the membrane to
adopt TM configuration from a more superficial membrane surface configuration than
peptides with no cargo, which are more membrane-embedded at high and neutral pHs.
Insertion/folding transitions to intermediate pHs
To further study the intermediate states of insertion, we compared transitions from
pH8 to 3.6 and intermediate pHs (pH86, pH85) (Fig. S6). When the size of the
pH jump is reduced, both peptide folding and bilayer insertion slow down. The first
(fast) rate of the insertion is very similar for all pHLIP variants (Table 3), and
coincides with the rate of helix formation; however, after the first 100-300 ms the
behaviors of the pHLIP variants are significantly different. The pHLIP-1 forms helical
structure and partitions into the lipid bilayer slightly slower when the pH is jumped
from 8 to 6 in comparison with the 8→3.6 pH jump. All processes are completed
within the first 200-300 ms for pHLIP-1 at any pH jump. It appears that the absence of
several protonatable groups at the inserting end makes the peptide less dependent on
the variations of the pH-jumps. In contrast, pHLIP-2 and pHLIP-4 insertion into the
membrane are more dependent on the final pH. Thus, the more protonatable groups
there are on the inserting end, the slower the process of insertion is at the intermediate
pH jumps. Interestingly, about 85% of the CD signal changes for both peptides occur
within the first 80 ms for all pH-transitions, while the rate constants for the remaining

90

15% of the CD signal changes correlate very well with the rate constant of the
fluorescence changes at the final step of the insertion and depend on the pH-jump
magnitude. It seems that the final adjustment of the content of helical structure occurs
at the final stage of insertion, when the peptides adopt TM orientations.
We observed an interesting behavior of pHLIP-4 when the pH was dropped from 8 to
6, and a “kink” in the fluorescence and CD kinetic curves appeared (Fig. 3). The
kinetic curves of the insertion and folding at the pH8→6 jump were fitted by threeexponential functions with negative amplitudes for the second component (shown in
red in Table 3). The physical meaning of a negative amplitude is that the spectral
signal changes in the opposite direction. These changes indicate that after the pH is
dropped, pHLIP-4 first partitions into the lipid bilayer with helical structure formation,
but later comes out of the membrane with a reduction of helical content, and then
finally “dives” into the membrane slowly with an increase of helical content.
Exit/unfolding of pHLIP variants
We also investigated the reverse processes of exit/unfolding of the pHLIP variants
when the pH is changed from 3.6 to 5, 6 and 8 (Fig. S7, Table 4). Our CD and
fluorescence data show very fast 50-150 ms exit transitions for each variant when the
pH is raised to 8. With a reduction of the sizes of the pH jumps, both unfolding and
exit from the bilayer slow down. As in the case of insertion/folding, the pHLIP-1
kinetics is less sensitive to the magnitude of the pH jumps than pHLIP-2 or -4. The
pHLIP-2’s exit/unfolding slows down from 200 ms for a pH3.6→8 jump to 60-80 sec
for a pH3.6→6 jump. Dramatic changes are observed for the pHLIP-4 with different
pH jumps: the exit/unfolding slows down from 200 ms to 150-170 sec.
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Insertion/folding and exit/unfolding of single-Trp pHLIP variants
Wishing to better understand the intermediates, we used tryptophan residues
positioned along the sequence to follow insertion and exit of different parts of pHLIP4 into and out of a lipid bilayer (Fig. 4, Table 5). The characteristic times of the
transitions for the single-Trp variants are similar to those of pHLIP-4, while double
the time is required for the pHLIP-W2 and -W3 to insert and adopt its final TM
configuration when the pH is dropped from 8 to 3.6. For the pH8→6 transition, a
“kink” is observed similar to that of pHLIP-4 within the same time scale of 4-7 sec.
The most pronounced kink is observed for the pHLIP-W3, and a less pronounced kink
is seen for pHLIP-W1 and -W2. As mentioned above, the kink is interpreted as a
partial exit and unfolding of the pHLIP-4 peptide in the path to the inserted and folded
state when the pH is dropped from 8 to 6. Based on this view, we infer that the Cterminal end of the peptide, which has four protonatable groups, tends to exit the
bilayer to a greater extent than other parts of the peptide.
Exit and unfolding for the pH3.6→8 transition happens fast for all single-Trp variants
(within 350 ms), but much more slowly for the intermediate transition driven by the
pH3.6→6 jump. (Fig. 4 c-d). Interesting changes were observed for pHLIP-W3 with a
pH increase from 3.6 to 6: while the fluorescence decays progressively for pHLIP-W1
and –W2, pHLIP-W3 exhibits an initial increase of fluorescence, which then decays
slowly. Our interpretation is that the changes are related to the movement of Trp
residues across the bilayer as the pHLIP-W3 peptide exits from the membrane.
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Rates of pH equilibration in POPC liposomes
It is known that the pH inside a liposome equilibrates progressively with the external
pH after a pH jump (24). However, the rate of equilibration depends on the magnitude
of the pH changes, the concentrations of other ions present, the charges on the lipid
headgroups, the buffering capacities inside and outside of the vesicles, and other
factors. One of the widely used methods to follow changes is to monitor fluorescence
changes of the pH-sensitive dye fluorescein (FITC) encapsulated into the liposomes.
FITC carries 2 negative charges at pH9 that are protonated as the pH is lowered. Since
some of the charged residues of pHLIP peptides are located near the bilayer surfaces
(on inner or outer leaflets), we chose to use lipid bound FITC to probe pH changes
near the inner leaflet rather than bulk pH changes. We followed pH equilibration after
the addition of acid or base using liposomes containing 1% FITC labeled
phospholipids. Biphasic kinetics were seen for a pH jump from pH8→3.6 with
characteristic rates of about 0.04 and 0.003 sec-1 (Fig. S8a), the data are in a good
agreement with the rates measured previously (25). Thus the fastest component of the
pH changes inside a liposome is of the same order of magnitude as the slowest
component of pHLIP-4 insertion, while pHLIP-2, -2E and -1 peptides fold and insert
into the lipid bilayer much faster than the pH equilibrates on the bilayer inner leaflet.
In the case of a pH jump from pH8→6, the first component slows down to 110 sec
(0.009 sec-1) and the second component is not detectable within 20 min.
We also measured the FITC fluorescence changes when the solution pH is raised from
3.6 to pH 8 and to pH 6 by addition of NaOH (the solution already contained H+ and
Cl- ions to mimic our unfolding experiments). In both cases, the characteristic time of
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the first increase of FITC fluorescence associated with the pH changes on the inner
leaflet of the bilayer is about 20 sec (Fig. S8 c-d), after which it takes tens of minutes
for the pH to be fully equilibrated.
Discussion
In this study we designed several pHLIP variants and examined how elements of the
pHLIP peptide and polar cargoes attached to the inserting end determine the pathways
and kinetics of peptide insertion across and exit from a lipid bilayer. Based on our
results, we have

developed a

model that describes our current view of the

polypeptide membrane entry and exit pathways, as well as cargo translocation across
the bilayer (Fig. 5). The model assumes a sequential pathway for the processes of
insertion and exit, and takes the state II as a starting point, where the peptide is bound
to the surface of the lipid bilayer in predominantly unstructured configuration. A drop
of pH leads initially to the protonation (or partial protonation) of the carboxyl groups
located in the TM part of the peptide, which are positioned closer to the hydrophobic
core of the bilayer and, most probably, have the highest values in the sequences for the
pKa of protonation, since the other titratable groups are not as constrained by nearby
side chain hydrophobicity to lie near the interface. It is known that the pKa of the
protonation/deprotonation of residues depends on the dielectric properties of their
environment (26, 27), and it was shown previously that buried Asp residues in the Chelix of bacteriorhodopsin, from which pHLIP is derived, have higher pKa’s of
protonation than those exposed to a more polar aqueous environment (28). Protonation
of the carboxyl groups in the TM parts of pHLIP peptides induces a deeper penetration
of the peptide into the membrane, which is accompanied by the formation of
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secondary structure within the first 20-90 ms, stabilized by the formation of internal
H-bonds that result from the depletion of water in their environment. As a result, an
effective force directed toward the bilayer core ( ⃗ ) is created at the center of the TM
region where the hydrophobic Leu and protonated Asp residues are located. On the
other hand, at the negatively charged C-terminus (which most probably hasn’t been
protonated yet) and positively charged N-terminus, the net forces ( ⃗

) are directed

away from the bilayer core. This force became even stronger if polar cargo is attached
to the inserting end of the peptide. The difference in folding/insertion between pHLIP4, -2 and -1 peptides and peptides with and without polar cargoes corresponds to the
strength of the force pulling these sequences away from the membrane, which is the
greatest for pHLIP-4 with cargo (pHLIP-4 itself has four charged groups at its Cterminus), and smallest for pHLIP-1, which has only its C-terminal carboxyl group.
These forces account in part for the observation that the insertions of pHLIP-2 and -1
into a lipid bilayer are completed 10 and 100 times faster than the insertion of pHLIP4, since they bias the position of the peptide away from the energy barrier that must be
crossed. Moreover, the existence of a large pulling force at the C-terminus of pHLIP-4
may account for the stabilization of an additional intermediate on the insertion
pathway, which is most probably transient in the case of insertions of pHLIP-2 and -1.
In the case of the intermediate pH jump from 8 to 6 the probability of protonation of
the C-terminal carboxyl groups is even lower so the ⃗

force becomes more

significant, which may lead to partial exit of the pHLIP-4 peptide from the bilayer and
the reduction of helical content observed experimentally. Experiments with the singleTrp pHLIP-4 variants allowed us to demonstrate that the C-terminal part of the TM
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helix moves away from the membrane more than the N-terminal part, while the middle
of the TM helix does not move much.
The process of unfolding/exit is induced by a pH jump from acid to base, which most
probably leads to the de-protonation (or at least partial de-protonation) of Asp residues
located in the TM parts of the peptides. It results in the presence of charges that are
unstable in the membrane interior, and an outward force appears. As a peptide exits
from the bilayer, it progressively unfolds. We note that the folding/insertion
experiments, which are performed on liposomes, may mimic the real processes of a
polypeptide’s interaction with cellular membranes quite well, but have the
shortcoming that the pH difference that is present across the plasma membrane of a
living cell is absent. For a cell in a diseased tissue, the intracellular pH is around 7.27.4, while the extracellular pH is low. We expect that carboxyl groups translocated
across a bilayer are in their non-charged form, since the pH is equilibrated inside
liposomes. For a large pH jump, all pHLIP variants, regardless of the number of
protonatable groups at their C-termini, exit and unfold at least 100 times faster than
the pH starts to be equilibrated inside a liposome (about 20 sec), so the protonatable
groups can make the journey before they see the higher pH inside of liposome.
However, for the intermediate pH jumps the probability of deprotonation of carboxyl
groups in TM part is much lower, and the pH inside the liposome starts to equilibrate
faster (within 20 sec) than peptides exit (77-175 s). We assume that at least partial
protonation of the carboxyl groups at the inserted C-terminus would occur, and as a
result, a force directed toward the inside of a liposome ⃗⃗⃗⃗⃗
( ) is created. As with
insertion, the more charges there are at the C-terminus, the more time it takes for the
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process of the C-terminus translocation across a bilayer during exit. Our results are
consistent with this view, and also confirm our assumption that the peptides exit to the
surface of the outside leaflet. Otherwise, if the peptides were able to exit to the inside
of a liposome, then the exit rate would not depend on the number of protonatable
residues at the C-terminus, rather it would be affected by the N-terminus of the
peptides and would be highest for pHLIP-4, with fewer charged residues at its Nterminus.
In contrast to other known peptide-based delivery technologies, the selective direct
delivery of polar molecules across a membrane by the pHLIP peptide is achieved by
the pH-dependent folding and insertion of a monomer across a bilayer, enabling the
targeting of acidic tissues. By using variants of the pHLIP peptide and by attaching
polar cargoes to the inserting end, we have advanced our understanding of the
mechanism of membrane-associated folding/unfolding, providing mechanistic insights
on the formation of helical structures and the existence of intermediates, and the
mechanism of cargo translocation across the lipid bilayer of a membrane. Here we
summarize the main conclusions:
- The existence of intermediate states on the folding and unfolding pathways is not
mandatory and, in the simple case of a polypeptide with a non-charged and nonpolar inserting end, the folding and unfolding is seen as an all-or-none transition.
- If the peptide inserting end has charges or a polar cargo attached, an interfacial
helical intermediate will occur before a peptide propagates into the hydrophobic
core of a membrane.
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- The origin of the driving force for the interfacial helix to insert into a bilayer to
adopt a TM orientation might include the distortion of lipids by the partial surface
insertion of the peptide. When a polypeptide forms a rigid helical structure and
propagates deeply into one monolayer of a lipid bilayer, membrane tension and
instability are created (29).
- A consistent and significant experimental observation is that the formation of
secondary structure accompanies the partitioning of a polypeptide into a lipid
bilayer, and that peptide exit from a membrane occurs simultaneously with
unfolding on this timescale. The energetic cost of breaking backbone H-bonds
inside a bilayer appears higher than the cost of the membrane distortion created
by an asymmetric inclusion of helices in one leaflet of a membrane lipid bilayer.
- Our study provides useful principles for the design of drug delivery agents for the
translocation of molecules across membranes into the cells in acidic diseased
tissues. There are both thermodynamic and kinetic limitations for the direct
translocation of polar cargo across membrane by pHLIP. The following
parameters correlate inversely with increasing polarity of cargo attached to the
peptide inserting end: i) the depth of peptide partitioning onto the membrane
surface at neutral pH (state II) that increases the effective concentrations of cargo
molecules near the membrane surface, ii) the proportion of peptide molecules in
the membrane-inserted state (state III) associated with cargo translocation, and iii)
the rate of peptide insertion into a bilayer (transition from state II to III) that
moves cargo from the extracellular to the intracellular space.
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Tables
25ºC

18ºC

11ºC

7ºC

0.02 (44.4 – 45.3) for various temperatures
pHLIP-1 0.08 (12.6) 0.15 (6.72) 0.31 (3.26) 0.48 (2.10)
pHLIP-2

0.04 (22.70 – 22.72) for various temperatures
2.7 (0.37) 3.7 (0.27) 6.0 (0.17) 7.5 (0.13)

0.09 (11.1) for various temperatures
pHLIP-4 2.0 (0.45) 2.1 (0.43) 2.8 (0.32) 3.5 (0.26)
32 (0.031) 33 (0.030) 38 (0.026) 50 (0.020)
Table 1. Insertion at different temperatures (characteristic times, τ, sec, and rate
constants, k, sec-1 (shown in parentheses)). The first, second and third raw, for each
pHLIP variant, contain kinetics parameters for the fastest, slow and the slowest
transitions, respectively.
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no cargo
pHLIP-4

pHLIP-2

pHLIP-2E

biotin

biotin-Peg

0.07 – 0.15 (14.2 – 6.7) for various cargo
2 (0.45)
17 (0.05)
16 (0.05)
32 (0.03)
385 (0.0026)
416 (0.0024)
0.1 –0.6 (10 – 1.7) for various cargo
2.7 (0.37)
3.6 (0.25)
10.0 (0.09)
102 (0.0097)
253 (0.0039)
0.04 (22 – 25) for various cargo
0.2 (0.45)
1.4 (0.65)
3.4 (0.27)
80 (0.012)
90 (0.011)

Table 2. Insertion with cargoes (characteristic times, τ, sec, and rate constants, k,
sec-1 (shown in parentheses)). The first, second and third raw, for each pHLIP variant,
contain kinetics parameters for the fastest, slow and the slowest transitions,
respectively.
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pH 8-3.6
pHLIP-1 fluoresc.

pH 8-5

pH 8-6

0.02 (44.6 - 45.0) for various pHs
0.09 (10.3)
0.18 (5.6)
0.20 (5.0)

pHLIP-1, CD

0.09 (10.1) for various pHs

pHLIP-2 fluoresc.

0.08 (11.3 – 11.4) for various pHs
2.8 (0.36)
4.5 (0.22)
13.0 (0.08)

pHLIP-2
CD

0.08 (11.3 – 11.4) for various pHs
2.2 (0.46)
5.0 (0.20)
13.0 (0.08)

pHLIP-4 fluoresc.

pHLIP-4
CD

0.09 (11.1) for various pHs
2.0 (0.45)
3.4 (0.27)
5.0 (0.18)
32 (0.031) 102 (0.0097) 138 (0.0072)
0.09 (11.1) for various pHs
2.0 (0.45)
5.0 (0.18)
5.0 (0.18)
32 (0.031) 102 (0.0097) 138 (0.0072)

Table 3. Insertion and folding at different pH transitions (characteristic times, τ,
sec, and rate constants, k, sec-1 (shown in parentheses)). The first, second and third
raw, for each pHLIP variant, contain kinetics parameters for the fastest, slow and the
slowest transitions, respectively.
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pH 3.6-8
pHLIP-1 fluoresc. 0.14 (7.14)
pHLIP-1, CD

pH 3.6-7

pH 3.6-6

0.40 (2.5)

0.85 (1.18)

0.02 (45.5) for various pHs

pHLIP-2 fluoresc.

0.03(29.9)
0.21 (4.81)

0.3 (3.01)
4.8 (0.21)

8.1 (0.11)
67.7 (0.015)

pHLIP-2
CD

0.02 (50)

0.3 (3.01)
3.9 (0.26)

8.0 (0.11)
77.0 (0.013)

pHLIP-4 fluoresc
pHLIP-4
CD

0.03 (29.9) 0.22 (4.12) 16.8 (0.054)
0.2 (5.05) 11 (0.092) 175 (0.0058)
0.02 (50)

0.22 (4.12) 16.8 (0.054)
6.5 (0.16) 149 (0.0068)

Table 4. Exit and unfolding at different pH transitions (characteristic times, τ, sec,
and rate constants, k, sec-1 (shown in parentheses)). The first and second raw, for each
pHLIP variant, contain kinetics parameters for the fastest and slowest transitions,
respectively.
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pHLIP-W1
pH 83.6
pH 8-6

pH 3.68
pH 3.66

pHLIPW2

pHLIPW3

0.09 (11.1) for various pHLIPs
2.5 (0.36)
35 (0.028) 76 (0.013) 71 (0.014)
0.01 (100) for various pHLIPs
4.0 (0.22)
2.6 (0.35) 6.2 (0.14)
200 (0.005) for various pHLIPs
0.04 (22.5)

0.05
0.06
(18.0)
(14.9)
0.35 (2.88) for various pHLIPs

4.2 (0.21)
54.9 (0.02)

-

-

-

-

Table 5. Insertion and exit of single-Trp pHLIP variants at various pH
transitions (characteristic times, τ, sec, and rate constants, k, sec-1 (shown in
parentheses)). The first, second and third raw, for each pHLIP variant, contain kinetics
parameters for the fastest, slow and the slowest transitions, respectively.
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Figures

Figure 1.

Insertion kinetics of pHLIP-4, -2, -1 at different temperatures, with

Arrhenius plots. Arrhenius plots are shown for the second and third rates. The data
were fitted by the Arrhenius equation, the fitting curves are colored in red.
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Figure 2. Insertion of pHLIP-4, -2, -2E with no cargo and with biotin and biotinPeg
cargoes attached to the inserting ends of the peptides. The fitting curves are colored in
red.
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Figure 3. “Kink” in the fluorescence and CD kinetic curves at the pH8→6 transition
for the pHLIP-4 variant.
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Figure 4. Insertion/exit of single-Trp pHLIP variants at different pHs. The fitting
curves are colored in red.
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Figure 5. Model of membrane-associated folding and unfolding. The schematic
presentation of the insertion/folding and exit/unfolding of pHLIP polypeptides. The
letter “W” indicates approximate positions of Trp residues in the single-Trp pHLIP-4
variants. Small red and blue circles represent the approximate positions of the
protonatable carboxyl groups of Asp, Glu and the C-terminus. The green circle
represents polar cargo attached to the inserting end of the peptide. Membrane
distortion is shown schematically by lipids with darker headgroups. In the case of
pHLIP peptides with no cargo and a non-protonatable C-terminal end, the insertion
and folding appears without intermediates as an all-or-none transition.
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Supporting material
Modulation of the pHLIP transmembrane helix insertion pathway

Alexander G. Karabadzhak1, Dhammika Weerakkody1, Dayanjali Wijesinghe1, Mak S.
Thakur1,
Donald M. Engelman2, Oleg A. Andreev1, Vladislav S. Markin3, Yana K. Reshetnyak1
Materials and methods
Synthesis of peptides
All variants were prepared by solid-phase peptide synthesis using Fmoc (9fluorenylmethyloxycarbonyl) chemistry and purified by reverse phase chromatography
at the W.M. Keck Foundation Biotechnology Resource Laboratory at Yale. The
lyophilized powder of each of the peptides was dissolved in a solution containing 3M
urea, and the peptides were transferred to buffer using a G-10 size-exclusion spin
column. The concentrations of the peptides were determined by absorbance (for
pHLIP-4, -2, -2E and -1: ɛ280 = 13,940 M-1 cm-1; for pHLIP-W1 and -W2: ɛ280 = 8,520
M-1 cm-1; and for pHLIP-W3: ɛ280 = 8,700 M-1 cm-1).

Conjugation of biotin and biotin-Peg to the pHLIPs
For conjugation with biotin and biotinPeg, pHLIP peptides were mixed with biotinmaleimide or biotin-dPeg3-maleimide (Quanta Biodesign Ltd) in DMSO at a ratio of
1:10 and incubated at room temperature for about 8 hrs and then at 4ºC until the
conjugation reaction was completed. The reaction progress was monitored by HPLC.
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The product was purified using reverse phase C18 HPLC, lyophilized and
characterized by SELDI-TOF mass spectrometry.

Liposome preparation
Large unilamellar vesicles were prepared by extrusion. 25 mg POPC (1-palmitoyl-2oleoyl-sn-glycero-3-phosphocholine, Avanti Polar Lipids, Inc.) or 99 mol% of POPC
and 1 mol% of fluorescein (FITC) DHPE (N-(fluorescein-5-thiocarbamoyl)-1,2dihexadecanoyl-sn-glycero-3-phosphoethanolamine,

triethylammonium

salt,

Invitrogen) lipids were dissolved in 2.5 ml chloroform and desolvated on a rotary
evaporator and dried under high vacuum for several hours. The phospholipid film was
then rehydrated in 10 mM phosphate buffer, pH 8.0, vortexed for 2 hours, and
repeatedly extruded through a membrane with either 100 or 50 nm pore sizes. The
concentration of the fluorescein lipids was determined by absorbance of FITC-DHPE

ɛ 496 = 89,000 M-1 cm-1.

Steady-state fluorescence and circular dichroism measurements
Tryptophan fluorescence and circular dichroism (CD) measurements were carried out
on a PC1 ISS spectrofluorometer (ISS, Inc.) and a MOS-450 spectrometer (Biologic,
Inc.), respectively, under temperature control. All measurements were performed at
25oC. Peptide fluorescence spectra were recorded from 310 nm to 410 nm with the
spectral widths of excitation and emission slits set at 4 and 2 nm, respectively, using
excitation wavelengths of 295 nm (excitation of 280 nm was selected for study
pHLIP-biotin constructs to reduce contribution of biotin). The polarizers in the

116

excitation and emission paths were set at the “magic” angle (54.7° from the vertical
orientation) and vertically (0°), respectively, to reduce Wood’s anomalies from the
reflecting holographic grating. Peptide CD spectra were recorded from 190 to 270 nm
with 0.5 nm increment using a cuvette with an optical path length of 0.5 cm. The
concentration of the peptides and POPC were 7 µM and 1.5 mM, respectively.

pH-dependence
pH-dependent partitioning of the peptides into a lipid bilayer of membrane was
investigated by the shift of the position of the fluorescence spectral maximum for the
pHLIP variants in the presence POPC liposomes induced by a drop of pH from 8 to 3
by addition of HCl. 3 μM of the peptide was incubated overnight with 2 mM of 100nm POPC liposomes, and pH decrease was achieved by the addition of aliquots of 4,
2, 1 and 0.1 M HCl. pH was measured by micro-electrode probe (Thermo Electron
Corporation, Orion Ross Micro pH electrode). Fluorescence spectra were recorded at
each pH value. The spectra were analyzed by the decomposition algorithms (40) using
on-line

PFAST

toolkit

(Protein

Fluorescence

And

Structural

Toolkit:

http://pfast.phys.uri.edu/) (41). The position of the fluorescence maxima (max) of
single-component solutions obtained in a result of decomposition were plotted versus
pH and the Henderson–Hasselbalch equation was used to fit the data (using Origin 8.5
software):
(

)
(
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)

where

and

are the beginning and end of the transition, n is the

cooperativety parameter, and pKa – is the midpoint of the transition. It is assumed that
there is a linear relation between the position of maximum and contribution of the
state II (or state III). However, due to the fact that the quantum yield in the states II
and III is different it contributed to slight non-linearity. We performed completed
analysis by estimating the contributions of states for pHLIP-4, which demonstrates the
biggest difference in fluorescence between states II and III and found out that the
apparent pK shifts no more than on 0.05 pH units toward lower pHs. Since the shift is
non-significant (less than the experimental error) we present values of pKa of
transitions from the state II to III, which were calculated based on the analysis of the
position of maximum of single-component decomposition of original spectra.

Oriented circular dichroism measurements
Oriented circular dichroism was measured from supported bilayers deposited on a
stack of quartz slides with special polish for far UV measurements, with spacers of 0.2
mm thickness on one side of each slide (Starna). Quartz slides were cleaned by
sonication for 10 min in cuvette cleaner solution (Decon Contrad 5% in water), 2propanol, acetone, 2-propanol and rinsed with deionized water. Then the slides were
immersed in a mixture of concentrated sulfuric acid and hydrogen peroxide (ratio 3:1)
for 5-10 min to completely remove any remaining organic material form the slides.
Slides were then thoroughly rinsed with and stored in deionized water (Milli-Q
purified water kept at 25 °C). A POPC lipid monolayer was deposited on the clean
quartz substrate by the Langmuir-Blodgett (LB) method using a KSV minitrough. For
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the LB deposition, a POPC lipid solution in chloroform was spread on the subphase
and allowed to evaporate chloroform for about 30 min, followed by monolayer
compression to 32 mN/m. An initial layer was deposited by retrieving the slide from
the subphase at a rate of 15 mm/min. The second layer of the bilayer was created by
fusion. For this step, the monolayer on the slide was incubated with a solution of
POPC vesicles (50 nm in diameter obtained by extrusion) mixed with the peptide
solution at pH 4 (0.5 mM POPC and 10 μM peptide). The fusion occurred during 6
hour incubation at 100% humidity. Then, excess vesicles were carefully removed and
the slides were stacked to make a pile filled with the peptide solution (5 μM) at pH 4.
Bilayers with the peptide solution were allowed an additional 6 hour equilibration.
Measurements were taken at 3 steps during the process: when the monolayers were
incubated with the excess of liposomes, soon after spaces between slides were filled
with the peptide solution and 6 hours after the second measurement. 14 slides (28
bilayers) were assembled and OCD spectra were recorded on a MOS-450 spectrometer
with 2 s sampling time. Control measurements were carried out of the peptide between
slides with and without supported bilayers and in the presence of an excess of POPC
liposomes.
Octanol-water partition coefficient measurements
The polarity of biotin-maleimide and Peg-biotin-maleimide was determined by the
assessment of the relative partitioning between aqueous and octanol liquid phases. The
biotin and biotin-Peg was dissolved in a 10 mM phosphate buffer pH8 (0.5 ml)
followed by the addition of n-octanol (0.5 ml). The solutions were mixed by vortexing
for 24 hrs at room temperature and then left for another 48 hrs in order to reach

119

equilibrium. After the phase separation, the absorption maximum of biotin at 300 nm
was recorded for each phase. The molar extinction coefficients in n-octanol and
phosphate buffer are assumed to be the same, and the ratio of the OD readings was
used directly to calculate the partition coefficients, P = ODn-octanol/ODwater, and
Log10 P values, which reflect the relative polarity of the cargoes.
Stopped–flow fluorescence and CD measurements
Stopped–flow fluorescence and CD measurements were carried out on a SFM-300
mixing apparatus connected to a MOS-450 spectrometer (Biologic, Inc.) under
temperature control. The FC-20 and TS-100/15 observation cuvettes were used for the
fluorescence and CD measurements, respectively. All solutions were degassed several
minutes under a vacuum before loading into the syringes to minimize air bubbles.
pHLIP variants (7 μM) were pre-incubated with POPC (1.5 mM) at pH 8.0 to reach
binding equilibrium and folding/insertion was induced by fast mixing (5 ms dead
time) of equal volumes of pHLIP-POPC variants at pH 8.0 and appropriately diluted
HCl, to obtain a drop of pH from 8 to the desired value. At peptide (pHLIP-4) and
lipid concentrations of 7 M and 1.5 mM, respectively, more than 95% of the peptide
is bound to the lipid bilayer of POPC liposomes according to our previous
thermodynamic studies (15, 16). In the case of pHLIP-2, -2E and -1, stronger binding
of the peptides to the membrane at pH8 is expected and therefore a smaller amount of
the unbound peptide. In a separate control experiment we assessed changes of
tryptophan fluorescence of the peptide in solution as a result of a pH drop in the
absence of liposomes. Reduction of the pH is accompanied by a blue shift of the
fluorescence emission of the peptide in solution (due to partial aggregation), but no
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increase of fluorescence intensity is observed. Therefore, increase of fluorescence
signal observed in the presence of liposomes reflects only the process of peptide
partition into the bilayers. In the unfolding experiments, pHLIP variants were preincubated with POPC at pH 8.0, then HCl was added to lower the pH to 3.6, and half
an hour was allowed for equilibration. Unfolding was induced by rapidly mixing equal
volumes of pHLIP-POPC variants at pH 3.6 and diluted NaOH to increase the pH
from 3.6 to the desired value. The mixing conditions and the concentrations of the
peptide and lipids were optimized to ensure i) the proper rapid mixing of the entire
volume of the sample to get the target changes of pH; ii) the best signal to noise ratio
and iii) a minimal disruption of liposomes, which was assessed by changes of the
scattered light signal. In the majority of cases, samples were collected after the
stopped-flow shots and the steady-state fluorescence spectra were recorded on a PC1
spectrofluorometer. Changes of the pHLIP fluorescence signal were recorded through
a 320 nm cutoff filter using an excitation wavelength of 295 nm (280 nm in case of
pHLIP-biotin to minimize absorbtion of biotin). The fluorescence signal was corrected
for photobleaching. Each kinetic curve was recorded several times (~10) and then
averaged, excluding the first 2-3 shots. Changes of the pHLIP CD signal were
recorded at 225 nm. About 20 shots were performed and CD signals were averaged.
Kinetics signals were recorded with increasing step. It allows reducing number of
points at long time scale. As a result, the signal at short time scale is noisier compared
to the signal at long time scale.
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Probing pH changes on the lipid bilayer inner leaflet by FITC fluorescence changes
To probe the kinetics of pH changes on the inner leaflet of vesicle lipid bilayers when
the external pH is suddenly changed, we used POPC liposomes containing 1 mol% of
FITC-DHPE. FITC-DHPE is a pH-sensitive fluorescent dye conjugated with lipid
headgroups, and the dye absorbance and fluorescence decreases with a decrease of the
pH from 9 to 4. The pH83.6 transition was induced by fast mixing (5 ms dead time)
of 1.5 mM of POPC-FITC liposomes and HCl. To raise the pH, we rapidly mixed
fluorescent liposomes, which were pre-mixed with HCl and had equilibrated at pH4
inside and outside the vesicles, with diluted NaOH. Different ratios were used to
induce pH3.66 and pH3.68 transitions. FITC fluorescence emission changes were
recorded at 519 nm using an excitation wavelength set at 496 nm.
Data analysis
The kinetic equations were solved in Mathematica 7 (Wolfram Research). Nonlinear
least squares curve fitting procedures using Levenberg-Marquardt algorithm were
carried out in Origin 8.5.0 SR1 and MatLab 2009b (7.9.0.529 version). The aim of
curve fitting was to find the best fit of the experimental data to minimize the
deviations of the theoretical curve from the experimental points (chi-square
minimization). In each case we selected the solution with the minimal number of
exponents that provide a fit of the experimental data within experimental error, the
results are obtained within 95% confidence interval. We carried out global fitting
when some characteristic times were used as shared parameters in the common fitting
of kinetic curves obtained at different temperatures or different pHs. The global fitting
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allows reduction of the number of variable parameters and gives a more reliable
solution. An F-test was used to compare fits of different models to select the best one.
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Tables

State I

State II

State III

Increase of Area for pHLIP-4 is 1.54 and 2.15 in states II and
III
pHLIP-4-bt

351.3 nm
max
1.0
S
3
225 x10 -1.43

349.5 nm
1.23
-1.56

340.9 nm
1.48
-6.05

pHLIP-4-btPeg

351.5 nm
max
1.0
S
3
225 x10 -1.44

349.7 nm
1.24
-1.76

341.3 nm
1.53
-6.04

Increase of Area for pHLIP-2 is 1.86 and 2.20 in states II and
III
pHLIP-2-bt

351.5 nm
max
1.0
S
3
225 x10 -1.39

345.6 nm
1.51
-2.41

340.0 nm
1.96
-6.33

pHLIP-2-btPeg

350.3 nm
max
1.0
S
3
225 x10 -0.99

347.5 nm
1.28
-1.43

338.6 nm
1.99
-5.05

Increase of Area for pHLIP-2E is 2.54 and 2.64 in states II and
III
pHLIP-2E

pHLIP-2E-bt

max
S
225
x103

349.0 nm
1.0
-1.10

341.3 nm
2.54
-4.42

339.2 nm
2.64
-6.36

max
S

350.7 nm
1.0
-1.89

344.7 nm
1.71
-3.96

340.1 nm
2.41
-6.09

350.9 nm
1.0
-1.61

347.9 nm
1.50
-2.27

340.1 nm
2.26
-5.05

225
x103
pHLIP-2EbtPeg

max
S
225
x103

Table S1. Three states of the pHLIP-cargo constructs. The spectral parameters of
the pHLIP-4, -2 and 2E conjugated to the biotin and biotin-Peg cargoes in the states I,
II and III are presented. The parameters were obtained from the analysis of the
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fluorescence and CD spectra shown on the Figure 3 supporting material: the maximum
position of the fluorescence spectrum max, S – the normalized area under the spectra
(normalization was done on the area under the spectrum in the state I); 225 x 103, deg
cm2 dmol-1 – the molar ellipticity at 225 nm.
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Figures

Fig. S1. pHLIP-2 and -1 variants show three states and pH-dependent insertion
into a membrane. Three states of the pHLIP-2 and -1 variants monitored by the
changes of the steady-state tryptophan fluorescence (a, d) and CD (b, e) spectroscopic
signals are presented (state I is the peptide in solution at pH8; state II is the peptide in
the presence of POPC liposomes at pH8; state III represents the peptide with POPC,
when the pH was dropped from 8 to 3.6 by the addition of an aliquot of HCl). OCD
signals (green lines on the b, e) demonstrate the transmembrane orientation of the
helices at low pH. The pH-dependent insertion into the lipid bilayer of the membrane
for the pHLIP-2 and -1 is shown on c and f, respectively. The experimental points
were fitted by the Henderson–Hasselbalch equation, the fitting curves are colored in
red.
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Fig. S2. Single-Trp pHLIP variants show three states. Three states of the singleTrp pHLIP variants (pHLIP-W1, -W2, -W3) were seen as monitored by the changes of
the steady-state tryptophan fluorescence (a, c, e) and CD (b, d, f) spectroscopic
signals. OCD signals (green lines on the b, d, f) demonstrate the transmembrane
orientation of the helices at low pH.
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Fig. S3. Three states monitored by the changes of fluorescence and CD for
pHLIP-cargo constructs. Three states of the pHLIP-4, pHLIP-2 and pHLIP-2E with
the biotin and biotingPeg cargoes monitored by the changes of the steady-state peptide
fluorescence and CD are presented (state I corresponds to the peptide-cargo in solution
at pH8; state II corresponds to the peptide-cargo in the presence of POPC liposomes at
pH8; state III corresponds to the peptide-cargo with the POPC, when the pH was
dropped from 8 to 3.6 by addition of aliquot of HCl).
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Fig. S4. pH-dependent insertion into lipid bilayer of the membrane of the pHLIP-2bt (a) and the pHLIP-2E-bt (b) is shown. The pKa of the transitions were found by the
fitting of the curves with the Henderson–Hasselbalch equation. The fitting curves are
colored in red.
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Fig. S5. pHLIP-6 show three states and pH-dependent insertion and exit from a
membrane. Three states of the pHLIP-6 monitored by the changes of the steady-state
tryptophan fluorescence (a) and CD (b) spectroscopic signals are presented (state I is
the peptide in solution at pH8; state II is the peptide in the presence of POPC
liposomes at pH8; state III represents the peptide with POPC, when the pH was
dropped from 8 to 3.6 by the addition of an aliquot of HCl). Kinetics of the insertion
into membrane (c) and exit from the lipid bilayer (d) for the pHLIP-6 are shown.
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Fig. S6. Insertion and folding of pHLIP-4, -2 and -1 variants at different pHs.
Kinetics of the fluorescence and CD changes recorded at different pH jump transitions
(pH 8→6 - blue line; pH 8→5 green line; and pH 8→3.6 black line) for pHLIP-1 (a),
pHLIP-2 short time scale (b) and long timescale (e-f), pHLIP-4 short time scale (c)
and long timescale (g-h) are presented. Representative kinetics of the CD changes for
the pH8→3.6 transition are shown (d) (similar signals were obtained for all pHLIP
variants). All fitting curves are colored in red.
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Fig. S7. Exit and unfolding of pHLIP-4, -2 and -1 variants at different pHs.
Kinetics of the fluorescence and CD changes were recorded at different pH jump
transitions (pH 3.6→6 - blue line; pH 3.6→7 - green line; and pH 3.6→8 - black line)
for pHLIP-1 (a), pHLIP-2 short time scale (b) and long timescale (e-f), pHLIP-4 short
time scale (c) and long timescale (g-h) are presented. Representative kinetics of the
CD changes for the pH3.6→8 transition are shown (d) (similar signal was obtained for
all pHLIP variants). All fitting curves are colored in red.
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Fig. S8. Changes of FITC fluorescence on the inner leaflet of a bilayer in a result
of pH drop or increase. POPC liposomes containing 1% of lipids with headgroups
conjugated with pH-sensitive dye, FITC, were used to probe pH changes on inner
leaflet of bilayer in a result of pH decrease (a, b) and increase (c, d). The kinetics of
fluorescence changes were monitored at 519 nm with excitation at 496 nm. The fitting
curves are colored in red.
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Appendix 1
Two-State model
The two-state model is used to describe fast processes of folding of the pHLIP-2E
variant, kinetic curves of which are fitted well by the single-exponential function. This
model doesn’t assume existence of intermediate states.

(1.1)
The transition from the state A to B is described by the differential equation:
(1.2)
(1.3)
The variables A and B designate relative populations of the corresponding states. k1
and kˉ1 are the rates constant for the forward and backward reactions, respectively.
We assume that initially all pHLIP molecules are in the state A and hence the initial
conditions are:
A(0) = 1, B(0) = 0

(1.4)

Exact solution of the differential equation 1.2 is the single-exponential function:
( )

(

)

(

)

(1.5)

Some of the CD kinetic data were fitted by the single-exponential function:
(

)

(1.6)

where the characteristc rate ν1 expressed in a form of the rate constants is:
(1.7)
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If we assume that equilibrium between the states A and B is strongly shifted to the
right, meaning that k1 >> kˉ1 and the difference between the rate constants at least an
order of magnitude:
(1.8)

then we can estimate the rate of the forward reaction from the characteristic rate
obtained in result of fitting of experimental data by single-exponential function:
(1.9)
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Appendix 2
Three-State model
In the majority of cases it was not possible to get an adequate fitting of the
experimental data by the single-exponential function. Therefore we introduced a threestate model, which assumes the existence of a single intermediate:

(2.1)
The transitions from one state to another are described by the differential equations:
(2.2)
(

)

(2.3)
(2.4)

The variables A, B and C designate relative populations of the corresponding states.
We assume that initially all the pHLIP molecules are in the state A and hence the
initial conditions are:
A(0) = 1, B(0) = C(0) = 0

(2.5)

Finally the equilibrium will be reached and the equilibrium populations can be easily
found by the graph technique (Markin, V. S., and Y. A. Chizmadzhev. 1974. Induced
Ion Transport. Nauka, Moscow), where the arrows represent corresponding transitions
in the scheme (2.1) and can be substituted with their rate constants:

(2.6)
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To obtain the time evolution of all states one can exclude B and C from the system
(2.2-2.4) and obtain the differential equation for A:
(

)

(

)

(2.7)

In general form the solution of the equation 2.7 is given by the two-exponential
function:
( )

(

)

(

)

(2.8)

where the characteristic rates v1 and v2 are expressed in the form of rate constants:
(

)

√ (

)

(

)
(2.9)

(

)

√ (

)

(

)
(2.10)

The population of the state B is found from the equation 2.2:

(

)

(

)

(

)

(

)

(2.11)

and finally the population of the state C is given:

(

)

[

]

(

)

[

]

(

)

(2.12)

Thus, the population of the states B and C can be expressed via A0, A1, and A2. Taking
into account that A(0) =1 and B(0) = 0 we can obtain:
(2.13)
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(

)

(

)

(2.14)

Solving the equations (2.13) and (2.14) one can find:
(2.15)
(

)

(

(2.16)
)

(2.17)

If the transitions between the states B and C are much slower than between the states A
and B, then the equations 2.15-2.17 could be significantly simplified and the
amplitudes A0, A1, and A2 can be expressed via the rate constants ki in a closed form:
[

(

)

(

)(

(

)

]

(2.18)

)

[

(

]

)

(2.19)

Let us designate the spectral (fluorescence or CD) signal of the different states A, B
and C by SA, SB, SC. Then the spectral signal of the whole system is:
Stheor = SA A + SB B + SC C

(2.20)

Substituting here the expressions for the populations of the different states using
equations 2.8; 2.11 and 2.12 one can obtain:
(

[
)]

(

(

)[

(

)]+
)

(

)[
)]

(

)

(

(2.21)

Experimentally it was found that most of the pHLIP-1 and -2 kinetic curves could be
adequately fitted by the two-exponential function:
(

)

(

)
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(2.22)

Therefore the experimental measurements Sexp provide five parameters: two
characteristic rate constants v1 and v2 and three characteristic fluorescence amplitudes
g0, g1 and g2. Comparing Stheor and Sexp we can find the relationships between the
theoretical and experimental parameters:
(

)

(2.23)

[

(

)]

(2.24)

[

(

)]

(2.25)

And the rates are given by the equations 2.9 and 2.10. Unfortunately, the theoretical
description involves seven parameters: four rate constants k1, kˉ1, k2, and kˉ2, and three
fluorescence/CD amplitudes SA, SB, SC against five experimental parameters, which
make it impossible to find the parameters unless we would make assumptions. First,
we concentrate our attention only on the rate constants. Second, we noticed that v1 >>
v2, thus the equations 2.9 and 2.10 can be expanded into a series. The major terms in
this expansion are:
(

)

(

(

(2.26)

)

(2.27)

)

If we assume that the equilibrium between the states A, B and C is strongly shifted to
the right, meaning that k1 >> kˉ1 and k2 >> kˉ2, and the difference between the rate
constants is at least an order of magnitude:
,

(2.28)
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then the rate of the forward reaction could be estimated from the characteristic rate
obtained as the result of the fitting of the experimental data by the single-exponential
function:
(2.29)
(2.30)
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Appendix 3
Four-state model
The adequate fitting of the pHLIP-2E-bt and -btPeg kinetic data was achieved only by
the three-exponential function. Therefore we introduced four-state model, which
assumes existence of two intermediates:

(3.1)
The transitions in this system are described by the set of equations:
(3.2)

(

)

(3.3)

(

)

(3.4)
(3.5)

The variables A, B, C and D designate relative populations of the corresponding states.
We assume that initially all pHLIP molecules are in the state A and hence the initial
conditions are:
A(0) = 1, B(0) = C(0) = D(0) = 0

(3.6)

Finally the equilibrium will be reached and the equilibrium populations can be easily
found by the graph technique:
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(3.7)

Solution of these equations is given by the three-exponential functions with the
characteristic rates v1, v2, v3 and it is rather cumbersome. We can assume that the first
transition is very fast and the equilibrium is strongly shifted toward the state B, which
means kˉ1  0. Then
v1 ~k1,

(3.8)

and
( )

(

)

(

)

(3.9)

Remaining equations are:
(

)

(3.10)

(

)

(3.11)
(3.12)

To solve this set one can exclude D:
(

)

(

)

and then exclude C:
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(3.13)

(

)

)

(

(

(

)

)

(

)

(3.14)

Solution of this differential equation is given by
(

)

(

)

(

)

(3.15)

with similar expressions for C and D. The first characteristic rate v1 is given by the
equation 3.8, and v2 and v3 are determined by:

(

)

(

)

(

√

)

√(

)

(

)
(3.16)

If we assume that the rates of consequent stages significantly decrease, i.e. k2, kˉ2 >> k3,
kˉ3, then one can expand expression 3.16 into series and find solution in a simple form:
(

)

(

(

(3.17)

)

(3.18)

)

We can reasonably assume that the equilibrium (3.1) between the states B, C and D is
strongly shifted to the right, meaning that k2, >> kˉ2

and

k3 >> kˉ3. The difference

should be at least an order of magnitude:
(3.19)
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and the rate constants are:
(3.20)
(3.21)
(3.22)
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Abstract
Cancer is a complex disease with a range of genetic and biochemical markers within
and among tumors, but a general tumor characteristic is extracellular acidity, which is
associated with tumor growth and development. Acidosis could be a universal marker
for cancer imaging and the delivery of therapeutic molecules, but its promise as a
cancer biomarker has not been fully realized in the clinic. We have discovered a
unique approach for the targeting of acidic tissue using the pH-sensitive folding and
transmembrane insertion of pH (low) insertion peptide (pHLIP). The essence of the
molecular mechanism has been elucidated, but the principles of design need to be
understood for optimal clinical applications. Here, we report on a library of 16
rationally designed pHLIP variants. We show how the tuning of the biophysical
properties of peptide–lipid bilayer interactions alters tumor targeting, distribution in
organs, and blood clearance. Lead compounds for PET/single photon emission
computed tomography and fluorescence imaging/MRI were identified, and targeting
specificity was shown by use of noninserting variants. Finally, we present our current
understanding of the main principles of pHLIP design.
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Introduction
The promise of exploiting tumor acidosis as a cancer biomarker has not been fully
realized in clinical practice, even though the acidity has been a known property since
the work of Otto Warburg nearly a century ago. The problem has been to find a
practical way to target acidity. While studying membrane protein folding, we
discovered a peptide (pH (Low) Insertion Peptide called pHLIP) that reversibly folds
and inserts across membranes in response to pH changes, and this discovery has led to
a novel way to target acidic tissue. Our biophysical studies have revealed the
molecular mechanism of pHLIP action, which is based on the increase of
hydrophobicity of carboxyl groups when they become protonated under mildly acidic
conditions, leading to peptide insertion into a membrane (1-4). We have shown that
pHLIP can target acidic tissue and selectively translocate polar, cell-impermeable
molecules across cell membranes in response to low extracellular pH (1, 5-10). As
noted in the Molecular Imaging and Contrast Agent Database (MICAD) at NCBI, a
pHLIP labeled with a fluorescent dye or a PET-agent (64Cu-DOTA) is a marker for in
vivo acidity (1, 5, 6), and it has recently been reported that a pHLIP peptide labeled
with SPECT (99Tc) probe targets acidic tumors (7), as well as PET (18F) probe
(Daumar et al., in press in Bioconjugate Chemistry). All prior studies in vivo were
carried out with the WT-pHLIP sequence and showed that a good contrast and tumor
to blood ratio can be achieved only more than 24 hours after pHLIP injection, when it
has accumulated in the tumor and largely cleared from the blood (6, 7). However, for
the use of pHLIP-based radioactive imaging agents in the clinic, a more rapid
background signal reduction is absolutely essential. To address this important need, to
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tune tumor targeting properties, and to broaden our understanding of the molecular
mechanism of pHLIP action, we designed a set of 16 pHLIP variants based on
chemical and physical principles. Comprehensive biophysical studies performed with
non-labeled peptides were correlated with investigations of tumor targeting and organ
distributions of fluorescent versions of the pHLIP variants. As a result, a set of design
criteria has been established, and pHLIP candidates for imaging and therapeutic
applications, including lead compounds for PET/SPECT and fluorescence/MR
imaging, have been identified.
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Materials and methods
Conjugation of pHLIP variants with fluorescent dyes
pHLIP variant wer prepared by solid-phase peptide synthesis using Fmoc (9fluorenylmethyloxycarbonyl) chemistry and purified by reverse phase chromatography
at the W.M. Keck Foundation Biotechnology Resource Laboratory at Yale. For cell
and in vivo stides variatns were conjugated with AlexaFluor750-C5-maleimide,
Tetramethylrhodamine-5-maleimide, single isomer or BODIPY-TMR-C5-maleimide
(Invitrogen). The details of peptides conjugation could be found in Supplementary
data.

Steady-state fluorescence and circular dichroism measurements
Peptide intrinsic fluorescence and circular dichroism (CD) measurements were carried
out on a PC1 ISS spectrofluorometer (ISS, Inc.) and a MOS-450 spectrometer
(Biologic, Inc.), respectively, under temperature control at 25oC. Peptide fluorescence
spectra were recorded with the spectral widths of excitation and emission slits set at 4
and 2 nm, respectively, using excitation wavelengths of 295 or 280 nm. The
concentrations of the peptides and POPC liposomes were 7 µM and 1.5 mM,
respectively. The method of liposome preparation and oriented circular dichroism
measurments could be found in Supplementary data.

Titration experiments
Samples containing 5 µM of peptides and varying concentrations of lipids were
prepared using an electronic repeater pipette (Eppindorf). Different pHs were used for
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peptides with different pKas of insertion; the pH of the solution was one pH unit
below the apparent pK value for each peptide. The samples at high and low pHs were
allowed to equilibrate at 4C overnight or 2 hours, respectively, before the
measurements. The peptide intrinsic fluorescence spectra were measured using
280 nm excitation at 25C with the emission polarizer set at 90 to reduce t h e
contribution of scattered light. A series of POPC blanks with the same
concentrations of lipids at pH8 were measured with the same instrument settings and
were subtracted from the corresponding fluorescence spectra of peptides in the
presence of POPC. The areas under the emission spectra were calculated and the
values were normalized to the first point (the emission of the peptide in the absence of
POPC). The titration data were fitted by the peptide-membrane partition model to
calculate the mole-fraction partition coefficient, K

where F0 and F are the fluorescence intensity at the beginning and fluorescence
increase as a result of the titration (in our case F0 is 1), Clipids is the concentration of
lipids; W is the molar concentration of water (55.3 M). Nonlinear least squares curve
fitting procedures using Levenberg-Marquardt algorithm were implemented in Origin
8.5.0 SR1. The Gibbs free energy (G) was calculated according to the equation:
( )
Where R is the gas constant and T is the temperature in Kelvin.
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pH-dependence
The pH-dependent partitioning of the peptides into lipid bilayers was investigated by
the shift of the position of the peptide intrinsic fluorescence spectral maximum for the
pHLIP variants induced by a drop of pH from 8 to 3 by addition of HCl in the
presence of POPC liposomes. 3 μM of the peptide was incubated overnight with 2 mM
of 100-nm POPC liposomes, and the pH was decreased by the addition of aliquots of
4, 2, 1 and 0.1 M HCl. The resulting pHs were measured using a micro-electrode
probe (Thermo Electron Corporation, Orion Ross Micro pH electrode). Fluorescence
spectra were recorded at each pH value. The spectra were analyzed by decomposition
algorithms using an on-line PFAST toolkit (Protein Fluorescence And Structural
Toolkit: http://pfast.phys.uri.edu/) to obtain spectral maxima (max). Finally, the
positions of the fluorescence spectral maxima (max) of the single component solutions
were plotted versus pH and the Henderson–Hasselbalch equation was used to fit the
data:
(

)
(

)

where 1max and 2max are the beginning and end of the transition, n is the cooperativity
parameter, and the pKa is the midpoint of the transition. The details of assumptions
made for the analysis of pH-dependence data could be found in Supplementary.

Stopped–flow fluorescence measurements
Stopped–flow fluorescence measurements were carried out on a SFM-300 mixing
apparatus connected to a MOS-450 spectrometer (Biologic, Inc.) under temperature
control. All solutions were degassed for several minutes under vacuum before loading
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into the syringes to minimize air bubbles. pHLIP variants (7 μM) were pre-incubated
with POPC (1.5 mM) at pH 8.0 to reach binding equilibrium, and insertion was
induced by fast mixing (5 ms dead time) of equal volumes of pHLIP-POPC variants at
pH 8.0 and appropriately diluted HCl, to obtain a drop of pH from 8 to the desired
value. Each kinetic curve was recorded several times (~10) and then averaged,
excluding the first 2-3 shots.

Cell lines
Human cervix adenocarcinoma (HeLa) and human lung carcinoma (A549) cells were
acquired from the American Type Culture Collection. Human lung carcinoma and
human cervix adenocarcinoma with stable expression of green fluorescent protein
(GFP), A549-GFP and HeLa-GFP, respectively, were acquired from Cell Biolabs Inc.
Cells were authenticated, stored according to supplier’s instructions, and used within 3
months after frozen aliquot resuscitations. Cells were cultured in Dulbecco’s Modified
Eagle’s Medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 10
μg/mL of ciprofloxacin in a humidified atmosphere of 5% CO2 and 95% air at
37°C. The pH5.9 medium was prepared by mixing 13.3 g of dry DMEM in 1 L of
deionized water. Human cervical epithelial cells (HCvEpC), human mammary
epithelial cells (HMEpC) and human bronchial epithelial cells (HBEpC) were
acquired from Cell Applications Inc. Cells were authenticated, stored according to
supplier’s instructions, and used within 2 months. HCvEpC, HMEpC and HBEpC cells
were cultured in cervical, mammary and bronchial epithelial cell growth medium,
respectively, provided by Cell Applications Inc.
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Fluorescence Microscopy
HeLa-GFP and A549-GFP ells were grown in 35-mm dishes with 14-mm glassbottom windows coated with poly-d-lysine or collagen. Cells were washed with
DMEM not containing FBS, pH 5.9 or 7.4 and then incubated with 2 μM of Rho- or
BODIPY-labeled Var-3, K-Var3, Var7 or K-Var7 peptides at pH 5.9 or pH 7.4. After
30 minutes of incubation, cells were washed 4-5 times. Fluorescent images were
acquired with a Retiga CCD camera (Qimaging, Burnaby, BC, Canada) mounted to an
inverted Olympus IX71 microscope (Olympus America, Inc., Center Valley, PA).
The details of cellular uptake quantification could be found in Supplementary data.

Cytotoxicity Assay
HeLa, A549, HCvEpC, HMEpC or HMEpC cells were loaded in the wells of 96-well
plates (~5,000 cells per well) and incubated overnight. The increasing amounts of
pHLIP variants (1, 2, 4 and 8 μM) were added to HCvEpC, HMEpC or HMEpC cells,
or growth medium was replaced with the medium without FBS containing increasing
amounts of pHLIP in case and after 3 hours of incubation an equal volume of the
medium containing 20% of FBS was added in case of Hela and A549 cells. After 24,
48 and 72 hours of incubation, a colorimetric reagent (CellTiter 96 AQueous One
Solution Assay, Promega) was added for 1 hour followed by measuring absorbance at
490 nm to assess cell viability. All samples were prepared in triplicate. None of the
tested pHLIP variants showed any cytotoxic effect.
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Animal studies
Athymic female nude mice ranging in age from 4 to 6 weeks and weighing from 15 to
18 g were obtained from Harlan Laboratories (Indianapolis, IN). In total, 266 mice
were used in the experiments, and the number of mice used to study each pHLIP
variant can be found in Tables S2-S5 of the Supplementary Data. Mouse tumors were
established by subcutaneous injection of HeLa-GFP or A549-GFP cells (106 cells/0.1
ml/flank) in the right flank of each mouse. When tumors reached 5-6 mm in diameter,
tail vein injections of 40 μM of 100 μl of Alexa750-pHLIPs were performed. Animals
were imaged at 4 and 24 hours post-injection on a FX Kodak in-vivo image station
under gas anesthesia with supplemental heat provided to maintain core body
temperature. Animals were euthanized at 4 or 24 hours, and necropsy was performed
immediately after euthanization. Tumors and major organs were collected for further
imaging. The tumor/organ ratio was calculated according to the equation:

where Ftumor , Forgan and Fbackg are the mean fluorescence intensities of tumor, organ
and background signal, respectively. The contrast-to-noise ratio (CNR) was calculated
according to the equation:

where SDbackg is the standard deviation of the background signal. Fluorescence
intensity was obtained from image analysis using Kodak software. Statistical analysis
of the data was performed using the “Statistica 5.0” package. The p-level was
computed based on the two-tailed test. All animal studies were conducted according to
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an approved University of Rhode Island animal protocol (AN07-01-015), in
compliance with the principles and procedures outlined in the NIH Guide for the Care
and Use of Animals.
Results
Design of pHLIP variants
We have reported the basic molecular mechanism of the interaction of WT-pHLIP
with lipid bilayers (1, 3, 11). In these studies we found three states of the peptide:
State I, in solution as an unstructured monomer at neutral pH when no lipid membrane
is present; State II, bound at the surface of a lipid bilayer as a largely unstructured
monomer at neutral pH, and State III, inserted across the bilayer as a monomeric helix
at acidic pH. To broaden our understanding of the main principles of pHLIP peptide
interactions with membranes and to select the best sequences for clinical use, we
employed our knowledge and designed 16 variants of the WT-pHLIP (Var0)
sequence:
Var0-WT

ACEQNPIY

WARYADWLFTTPLLLLDLALLV DADEGT

Var1-2D1D ACEDQNPY

WARYADWLFTTPLLLLDLALLV DG

Var2-2D1D ACEDQNPY

WRAYADLFTPLTLLDLLALW DG

Var3-3D

ACDDQNP

WRAYLDLLFPTDTLLLDLLW

Var4-3E

ACEEQNP

WRAYLELLFPTETLLLELLW

Var5-3Da

ACDDQNP

WARYLDWLFPTDTLLLDL

Var6-3Db

CDNNNP

WRAYLDLLFPTDTLLLDW

Var7-3Ea

ACEEQNP

WARYLEWLFPTETLLLEL

Var8-3Eb

CEEQQP

WAQYLELLFPTETLLLEW

Var9-3Ec

CEEQQP

WRAYLELLFPTETLLLEW
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Var10-2D

ACEDQNP

WARYADWLFPTTLLLLD

Var11-2E

ACEEQNP

WARYAEWLFPTTLLLLE

Var12-1D

ACEDQNP

WARYADLLFPTTLAW

Var13-1E

ACEEQNP

WARYAELLFPTTLAW

Var14-Rev Ac-TEDAD

VLLALDLLLLPTTFLWDAYRAW YPNQECA-Am

Var15-2N

CDDDDDNPNY WARYANWLFTTPLLLLNGALLV EAEET

Var16-2P

CDDDDDNPNY WARYAPWLFTTPLLLLPGALLV EAEET

Biophysical studies
First, we studied the interaction of the pHLIP variants with lipid bilayers, employing
the fluorescence and CD spectroscopic techniques previously used (3). The intrinsic
tryptophan fluorescence and CD spectra of non-labeled variants measured in solution
at pH8 in the absence and presence of POPC liposomes and in the presence of
liposomes at low pH (pH 4-5) indicate that each peptide interacts with a lipid bilayer
in a pH-dependent manner and that the peptides form transmembrane helices in state
III (Supplementary Table S1 and Figure S1).
The partitioning of pHLIP variants into bilayers at pHs 8 and 4-5 was assessed in
titration experiments by measuring changes of intrinsic peptide fluorescence (Figure
1). On average, the partitioning of the variants into the membrane at low pH is about
50 fold higher than at high pH. As expected, the truncated variants Var5-13 have
lower affinities for the membrane at neutral pH compared to WT and other variants,
since a number of hydrophobic residues were removed from the sequences. In general,
variants with Glu residues have slightly higher affinities compared to the same
variants with Asp (since Glu is more hydrophobic due to the additional methylene
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group). The highest affinity was observed for Var15, which forms helical structure at
neutral pH. At low pH, the lowest affinity for the lipid bilayer was observed for the
most truncated versions Var10-13 and variants (Var15 and 16) with no protonatable
residues in the TM, which reflects the reduced stability of the TM helix. The numbers
below are the differences between the Gibbs free energies of the interactions of
variants with the membrane at low and high pHs (in kcal/mol): G = GpH4  GpH8
Var1 Var2 Var3 Var4 Var5 Var6 Var7 Var8 Var9 Var10 Var11 Var12 Var13 Var14
Var15 Var16
2.17 0.28 2.23 1.72 2.31 1.93 2.39 2.19 2.07 1.79
0.82

1.94

1.95

1.15

1.78

1.47

The above numbers reflect both the differences in binding affinities, and to some
degree, the strength of helical structure formation in the membrane. The largest
differences are observed for Var3, Var5 and Var7. The smallest differences are found
for Var2 and Var15 due to the strong interactions of these peptides with the bilayer in
state II at pH8.
The pKa of peptide insertion is determined by the pKa of protonation of Asp/Glu
residues in the TM and at the inserting end of the peptide. As charged carboxyl groups
located at the transition zone between the aqueous and hydrophobic environments sink
more deeply into the bilayer, the pKa is progressively raised by the reduced dielectric
constant, and the pKa of Asp/Glu residues increases. Thus, all truncated variants
(Var5-13), which demonstrated weaker interactions with lipid bilayer surfaces at
neutral and high pHs, would have lower pKa’s of insertion. The pKa of pHLIP variant
insertion was measured by following the shift of the position of the intrinsic peptide
emission maximum as the pH is changed from 8 to 2 (Figure 2). As expected, the shift
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of pKa to lower pHs correlates with the truncation of the pHLIP sequence. Thus, the
pKa of Var10, with a single Asp residue in its TM, is the lowest (pKa=4.5). All
variants containing Glu residues (Var7-9, 11, 13) have higher pKa values compared to
the related sequences with Asp residues (Var5-6, 10, 12), again as expected if the
increased hydrophobicity of the Glu causes a deeper association with the bilayer,
lowering the dielectric and raising the pK.
To this point, we have considered the equilibrium energies of progressive binding and
insertion events, but it is also important to note that sequence variation will alter the
kinetics of insertion. The barrier for insertion includes the resistance to the passage of
the inserting terminal end of the peptide from the aqueous compartment outside to the
aqueous compartment inside a cell or liposome. We have found in recent work that the
kinetics of insertion correlates with the number of protonatable groups at the inserting
end or the presence of polar cargo (12). The characteristic membrane insertion time
for WT-pHLIP is about 30 sec, and slightly faster kinetics were observed for Var14,
which is the reverse sequence of WT. Var14 has the same number of protonatable
residues at its N-terminus as WT has at its C terminus, except for the free C-terminus
itself. The data are consistent with the view that the acetylated N-terminus of Var14
inserts across the bilayer and the amidated C-terminus stays outside, reversing the
direction of insertion. The characteristic time of Var1-2 insertion, which has fewer
protonatable residues at its C-terminus than WT, was about 1-2 sec, which correlates
well with our recent findings (12). Further truncation of the peptide inserting end,
which reduces the number of protonatable residues, resulted in faster peptide insertion,
completed within first 30-100 msec for Var3-13. Var15-16 have no protonatable
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residues in the TM, while they have the same number of Asp/Glu as WT at the
inserting end, and as a result the time of insertion was reduced to 10-11 sec relative to
WT. The kinetics data are shown in Figure 3.
Tumor targeting and distribution of Alexa750-pHLIPs in organs
We used a mouse xenograft model to assess the tumor targeting and organ distribution
of the pHLIP variants. Tumors were created by subcutaneous injection of HeLa-GFP
cancer cells in the right flanks of each mouse, and were grown to about 5 mm in
diameter. To perform biodistribution studies, pHLIP variants were conjugated with
Alexa750. We demonstrated that the kinetics of insertion of Alexa750-WT-pHLIP into
lipid bilayers is similar to the kinetics of insertion of non-labeled peptide
(Supplementary Figure S2). Fluorescently labeled pHLIPs were given as single
intravenous injections, and the major organs and tumors were collected at 4 and 24
hours after fluorescent pHLIP administration. The GFP and NIR signals were
monitored in tumors and organs after sacrificing the mice. The mean intensities of
NIR fluorescence normalized to the signal in kidneys at 4 hours are shown on
Supplementary Figure S3. The mean intensities of NIR fluorescence of all organs and
the number of mice used in the study for each variant are given in Supplementary
Table S2 and Table S3.
The pHLIP variants that show higher affinities for membranes at high pH have higher
short-term liver uptake (Var 1, 2, 4, 14-16), however the liver is cleared at 24 h except
for Var1. Var3 has high tumor targeting compared to kidney and compared to other
pHLIPs as well. Whole-body (data not shown) and organ imaging confirmed that the
truncated variants Var5-13 have much faster blood clearance than WT, and at 4 hours
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the signal has accumulated in the tumor, while being washed out of the organs. Tumor
targeting was minimal for the shortest pHLIP variants Var12-13. The tumor/muscle,
tumor/kidney and tumor/liver ratios are given in Figure 4 for all pHLIP variants
calculated at 4 and 24 h after injection. Variants 0, 3-4, 14-16 have the highest
tumor/muscle ratio at 24 hours. The same pHLIP variants have the highest
tumor/kidney ratios, while only Var3 shows significantly less accumulation in the
liver. Among the truncated pHLIP variants, Var7 demonstrates the highest tumor
targeting.
This body of work allows us to propose different pHLIP variants for different
applications. We have selected Var3 and Var7 as the best candidates for future studies
for fluorescence/MRI and SPECT/PET imaging, respectively, guided by the fact that
the imaging time window for the stable fluorescence and MRI agents can be much
wider than for the short half-life SPECT and PET agents. Var3 had the highest
tumor/organ ratios, especially at 24 hours after construct administration. Var7 had a
lower tumor/organ ratio, but showed much faster blood clearance. The cytotoxicity of
the selected pHLIP variants was evaluated on human cervix adenocarcinoma cells
(HeLa), human lung carcinoma (A549) cells as well as human cervical (HCvEpC),
mammary (HMEpC) and bronchial (HBEpC) epithelial cells. Peptides at
concentrations of up to 8 μM were evaluated up to 72 hours incubation with cells, and
no toxicity was observed.
pH-insensitive K-pHLIPs
As a control, we have previously used K-pHLIP-WT, where the two key Asp residues
in the TM part of the peptide were replaced by Lys residues (1). K-pHLIP cannot
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interact with a membrane in a pH-dependent manner over the range of neutral and low
pHs we are studying, and therefore should not target acidic tumors. Because of the
potential clinical applications of Var3 and Var7 we synthesized and tested K-versions
of each:
K-Var3

ACDDQNP WRAYLKLLFPTKTLLLKLLW

K-Var7

ACEEQNP WARYLKWLFPTKTLLLKL

Each of these peptides failed to interact with lipid bilayers in a pH-dependent fashion
(Figure 5a-b). No shift in the position of the peptide fluorescence maximum was seen
for either of the K-pHLIPs in the presence of lipid as a result of pH decrease, and the
CD spectra do not change and do not exhibit the minimuma at 208 and 225 nm that are
characteristic signals reporting alpha-helical conformations. The CD spectra reveal a
negative band at 234 nm and a positive band at 221 nm, suggestive of an exciton split
doublet (3, 13) possibly arising from peptide aggregation.
Var3 and Var7, as well as K-Var3 and K-Var7 were conjugated with two different
fluorescent dyes: zwitterionic, tetramethylrhodamine (Rho), and non-charged,
BODIPY to ensure that distribution and localization of fluorescent peptides is
independent of the choice of dye. The fluorescence images demonstrating cellular
uptake of Rho- and BODIPY-labeled Var3, Var7, K-Var3 and K-Var7 are shown in
Figure 5c-d and Supplementary Figure S4, respectively. The fluorescence signal of
cells treated with fluorescent Var3 and Var7 at pH7.4 was weaker compare to cells
treated with peptides at pH5.9. The cellular uptake of Var3 was 1.12 times higher at
low pH compare to neutral pH, and uptake of Var7 was 1.34 times higher at low pH.
Our biophysical data show that the affinity of Var3 for a membrane at pH8 is higher
than the affinity of Var7 at the same pH, therefore we see slightly higher cellular
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uptake of Var3 at pH7.4 compare to Var7 and a less pronounced difference in cellular
uptake between neutral and low pHs for Var3. For the cases of K-Var3 and K-Var7,
the fluorescence signal was very similar when cells were treated at either high or low
pHs, moreover the fluorescence signal at pH7.4 was slightly higher than at pH5.9.
Also, the distributions of fluorescent signals for D- and E-variants and K-variants were
different. K-Var3 and K-Var7 were distributed as cytoplasmic dots. In contrast to
pHLIP variants, K-pHLIPs are positively charged and partially aggregated, and, most
probably, might be taken up by endocytosis and trapped in endosomes in a pHindependent manner, while cellular uptake of Var3 and Var7 is pH-dependent.
Biodistribution and tumor targeting of Alexa750-K-pHLIPs were also investigated
using xenograft models in mice. In contrast to Var3 and Var7, K-pHLIPs did not
show significant tumor targeting (Figure 5e-f and Supplementary Table S4). To
demonstrate that tumor targeting by Var3 and Var7 and the lack of tumor targeting by
K-Var3 and K-Var7 is independent of choice of tumor model and imaging fluorescent
probe, we used BODYPI labeled Var3, Var7, K-var3 and K-Var7, which were tested
on tumors created by subcutaneous injection of A549-GFP human lung carcinoma
cells. The organs were collected at 4 hours and analyzed (Supplementary Table S5).
The tumor to muscle ratio at 4 hours for Var3 and Var7 labeled with BODIPY and
Alexa750 was 6.00.9, while for K-Var3 and K-Var7 it was 2.60.3 (Figure 5g).
Thus, the replacement of the Asp/Glu residues by Lys in the TMs of Var3 and Var7
leads to the loss of both pH-dependent interactions with membranes and targeting of
acidic tumors, supporting a central role for the carboxyl groups in targeting.
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Discussion
Rapid cell growth and an inadequate blood supply produce hypoxic conditions that
cause a partial use of glycolysis in tumor cells, resulting in acidification of the cytosol,
to which the cell adjusts by pumping protons into the external environment. But,
hypoxia and low blood supply are not the only mechanisms responsible for the
development of an acidic environment within solid tumors (14). Malignant cancers
have an elevated glucose uptake even under normal oxygen conditions, overwhelming
the mitochondrial capacity and using glycolysis for the overflow. This condition is
known as “aerobic glycolysis” or the Warburg effect (15). Cells exhibiting a Warburg
effect catabolize glucose at a high rate (16, 17), and the use of glycolysis results in a
much higher level of production of H+ and lactic acid, which are pumped across cell
plasma membranes into the extracellular space, where they accumulate in poorly
perfused regions (18-20). In addition to the lactic acid-output, intracellular titration of
acid with bicarbonate and the engagement of the pentose phosphate shunt releases
CO2 from tumor cells. Expression of carbonic anhydrase 9 and 12 on the tumor cell
surface catalyzes the extracellular trapping of acid by hydrating cell-generated CO2
into HCO3− and H+ (21, 22). These mechanisms combine to create an acidic
extracellular milieu favoring tumor growth, invasion and development.
The pHLIP peptides can exploit tumor acidity as a useful biomarker. Based on the
results of our previous and current investigations, design principles can be formulated
to set directions for different clinical uses:
i)

all pHLIP peptides have a membrane-binding sequence, which contains a
number of hydrophobic residues essential for membrane targeting;
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ii)

a pHLIP is stable across a lipid bilayer at low pH;

iii)

to achieve pH-dependent targeting, at least one protonatable group (Asp or
Glu, or any other) needs to be in the sequence;

iv)

in addition to the membrane-binding sequence, a pHLIP peptide may
contain a membrane inserting sequence (the C-terminus for most
investigated pHLIPs or the acetylated N-terminus of the reverse pHLIP
sequence), which crosses the lipid bilayer and emerges in the cytoplasm.
The protonatable residues could be only in the inserting sequence or in
both the TM and inserting parts of the peptide;

v)

the number of protonatable residues increases the cooperatively of the
transition, narrowing the pH range over which insertion occurs;

vi)

the non-inserting flanking sequence may be used for modulation of peptide
solubility, for example by adding polar and negatively charged residues at
the non-inserting end (all pHLIP peptides are soluble in aqueous solution at
neutral and high pHs).

The list of the major biophysical properties that affect tumor targeting by pHLIP
peptides could be found in Supplement data.
Based on the studies reported here, and motivated by potential clinical applications,
we selected two pHLIP variants for further development (in addition to WT-pHLIP):
Var3 and Var7. For each of these variants we tested versions with the TM carboxyl
groups replaced by amino groups (D to K and E to K), and showed that the K-peptides
lose their abilities to interact with membranes in a pH-dependent manner and to target
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tumors in vivo. Var3 demonstrates high tumor to organ ratios at 24 hours (similar to
WT) and could be well suited for optical imaging or MRI one day after construct
administration. Var3 might also be suitable for fluorescence-guided surgery, marking
a tumor with fluorescently-labeled pHLIP and performing surgery on the next day,
when the contrast index is the highest. Var7 is one of the truncated versions of pHLIP,
which could be appropriate for SPETC/PET imaging, since it demonstrates fast tumor
targeting and blood clearance.
In this report, we show that the biophysical principles that guide pHLIP peptide
interactions with lipid bilayers can be used to determine peptide performance in vivo,
and we identify two pHLIP variants as appropriate candidates for uses in clinical
imaging of acidic tissues, such as solid tumors.
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FIGURE LEGENDS
Figure 1. Titration of pHLIP variant binding to liposomes at high and low pHs.
The titration of the pHLIP variants with increasing concentration of POPC liposomes
at pH8 (a) and pH4-5 (b) are followed using intrinsic peptide fluorescence changes.
For comparison the mole-fraction partition coefficients for Var0 (WT-pHLIP) at pH8
and 5 are 4.87x104 and 1.54x106, respectively, and the corresponding Gibbs free
energies are 6.04 and 7.98 kcal/mol.
Figure 2. pH-dependent bilayer insertion of variants. Peptide intrinsic fluorescence
changes are used to follow the insertion as a function of pH (transition from the state
II to state III as the pH is lowered).
Figure 3. Kinetics of insertion. Representative kinetic curves for the insertion of
variant peptides into the lipid bilayer are shown, the characteristic time of insertion of
Var0 (WT-pHLIP) is about 40 sec.
Figure 4. Tumor to organ fluorescence ratios. Tumor to muscle, tumor to kidney
and tumor to liver ratios calculated at 4 and 24 hour time points are shown for all
pHLIP variants.
Figure 5. Comparisons with control K-pHLIPs. The CD (a) and tryptophan
fluorescence (b) spectra of K-Var3 and K-Var7 show that these variants lose the
ability to interact with a lipid bilayer in a pH-dependent manner. (c-d) Cellular uptake
at pH7.4 and 5.9 of Var3, K-Var3, Var7 and K-Var7 labeled with Rhodamine are
shown. The cellular uptake of four peptides labeled with BODIPY are shown at both
pHs in Supplementary Figure S4. (e-f) Whole-body NIR fluorescence images of mice
obtained at 4 and 24 hours after i.v. administration of Var3, K-Var3 (e) and Var7, K-
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Var7 (f) conjugated with Alexa750. The tumor is indicated by arrows on the NIR
images as reported by the GFP signal shown in adjacent images. Images obtained at
different time points are presented with maximum contrast, the contrast-to-noise ratios
are: Var3, 4h – 103; Var3, 24h – 186; Var7, 4h – 85; Var7, 24h – 360; K-Var3, 4h –
87; K-Var3, 24h – 54; K-Var7, 4h – 22; K-Var7, 24h – 16. (g) The A549-GFP tumor
to muscle ratios calculated for 4 hours for BODIPY-pHLIPs and –K-pHLIPs and
HeLa-GFP tumor to muscle ratios calculated for 4 and 24 hours time points for
Alexa750-pHLIPs and –K-pHLIPs are shown. The mean fluorescence of HeLa-GFP
and A549-GFP tumors and organs at 4 and 24 hours after Alexa750-K-pHLIPs and at
4 hours after BODIPY-pHLIPs and –K-pHLIPs administration are given in the
Supplementary Table S4 and S5, respectively.
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Figures
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Figure 1. Titration of pHLIP variant binding to liposomes at high and low pHs.
The titration of the pHLIP variants with increasing concentration of POPC liposomes
at pH8 (a) and pH4-5 (b) are followed using intrinsic peptide fluorescence changes.
For comparison the mole-fraction partition coefficients for Var0 (WT-pHLIP) at pH8
and 5 are 4.87x104 and 1.54x106, respectively, and the corresponding Gibbs free
energies are 6.04 and 7.98 kcal/mol.

Figure 2. pH-dependent bilayer insertion of variants. Peptide intrinsic fluorescence
changes are used to follow the insertion as a function of pH (transition from the state
II to state III as the pH is lowered).
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Figure 3. Kinetics of insertion. Representative kinetic curves for the insertion of
variant peptides into the lipid bilayer are shown, the characteristic time of insertion of
Var0 (WT-pHLIP) is about 40 sec.

Figure 4. Tumor to organ fluorescence ratios. Tumor to muscle, tumor to kidney
and tumor to liver ratios calculated at 4 and 24 hour time points are shown for all
pHLIP variants.
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Figure 5. Comparisons with control K-pHLIPs. The CD (a) and tryptophan
fluorescence (b) spectra of K-Var3 and K-Var7 show that these variants lose the
ability to interact with a lipid bilayer in a pH-dependent manner. (c-d) Cellular uptake
at pH7.4 and 5.9 of Var3, K-Var3, Var7 and K-Var7 labeled with Rhodamine are
shown. The cellular uptake of four peptides labeled with BODIPY are shown at both
pHs in Supplementary Figure S4. (e-f) Whole-body NIR fluorescence images of mice
obtained at 4 and 24 hours after i.v. administration of Var3, K-Var3 (e) and Var7, KVar7 (f) conjugated with Alexa750. The tumor is indicated by arrows on the NIR
images as reported by the GFP signal shown in adjacent images. Images obtained at
different time points are presented with maximum contrast, the contrast-to-noise ratios
are: Var3, 4h – 103; Var3, 24h – 186; Var7, 4h – 85; Var7, 24h – 360; K-Var3, 4h –
87; K-Var3, 24h – 54; K-Var7, 4h – 22; K-Var7, 24h – 16. (g) The A549-GFP tumor
to muscle ratios calculated for 4 hours for BODIPY-pHLIPs and –K-pHLIPs and
HeLa-GFP tumor to muscle ratios calculated for 4 and 24 hours time points for
Alexa750-pHLIPs and –K-pHLIPs are shown. The mean fluorescence of HeLa-GFP
and A549-GFP tumors and organs at 4 and 24 hours after Alexa750-K-pHLIPs and at
4 hours after BODIPY-pHLIPs and –K-pHLIPs administration are given in the
Supplementary Table S4 and S5, respectively.
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SUPPLEMENTARY DATA
A Family of pH (Low) Insertion Peptides for Tumor Targeting
Dhammika Weerakkody, Anna Moshnikova, Mak S. Thakur, Valentina Moshnikova,
Jennifer Danniels, Donald M. Engelman, Oleg A. Andreev, Yana K. Reshetnyak

Conjugation of pHLIP variants with fluorescent dyes
The lyophilized powder of a peptide was dissolved in a solution containing 3M urea,
and the peptide solution was transferred to buffer using a G-10 size-exclusion spin
column, or was dissolved directly in phosphate buffer at pH8 for biophysical studies.
The concentrations of the peptides were determined by absorbance (for Var0-2 and
Var14-16: ɛ280 = 13,940 M-1 cm-1; and for Var3-13 and K-Var3, K-Var7: ɛ280 = 12,660
M-1 cm-1).
For studies on cultured cells and animals each pHLIP variant was conjugated with
AlexaFluor750 C5-maleimide (Invitrogen, catalog #A30459), and Var3, Var7, KVar3 and K-Var7 were conjugated with Tetramethylrhodamine-5-maleimide, single
isomer (Invitrogen, catalog #T6027) or BODIPY-TMR C5-maleimide (Invitrogen,
catalog #B30466) in DMF or DMSO at a ratio of 1:1.1 of dye:peptide and incubated at
room temperature for about 6 hours and then at 4ºC until the conjugation reaction was
completed. The reaction progress was monitored by reverse phase HPLC. The purity
of products was assessed by analytical HPLC and peak identity was confirmed by
SELDI-TOF mass spectrometry.
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Liposome preparation
Large unilamellar vesicles (LUVs) were prepared by extrusion. POPC (1-palmitoyl-2oleoyl-sn-glycero-3-phosphocholine, Avanti Polar Lipids,

Inc.) dissolved in

chloroform at a concentration of 1 mg/ml were desolvated on a rotary evaporator and
dried under high vacuum for several hours. The phospholipid film was then rehydrated
in 100 mM phosphate buffer, pH 8.0, vortexed for 2 hours, and repeatedly extruded
through membranes with 100 or 50 nm pore sizes to obtain LUVs.

Oriented circular dichroism measurements
Oriented circular dichroism was measured from supported bilayers deposited on a
stack of quartz slides with special polish for far UV measurements, with spacers of 0.2
mm thickness on one side of each slide (Starna). Quartz slides were cleaned by
sonication for 10 min in cuvette cleaner solution (Decon Contrad 5% in water), 2propanol, acetone, 2-propanol and rinsed with deionized water. Then the slides were
immersed in a mixture of concentrated sulfuric acid and hydrogen peroxide (ratio 3:1)
for 5-10 min to completely remove any remaining organic material form the slides.
Slides were then thoroughly rinsed with and stored in deionized water (Milli-Q
purified water kept at 25 °C). A POPC lipid monolayer was deposited on the clean
quartz substrate by the Langmuir-Blodgett (LB) method using a KSV minitrough. For
the LB deposition, a POPC lipid solution in chloroform was spread on the subphase
and allowed to evaporate chloroform for about 30 min, followed by monolayer
compression to 32 mN/m. An initial layer was deposited by retrieving the slide from
the subphase at a rate of 15 mm/min. The second layer of the bilayer was created by
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fusion. For this step, the monolayer on the slide was incubated with a solution of
POPC vesicles (50 nm in diameter obtained by extrusion) mixed with the peptide
solution at pH 4 (0.5 mM POPC and 10 μM peptide). The fusion occurred during 6
hour incubation at 100% humidity. Then, excess vesicles were carefully removed and
the slides were stacked to make a pile filled with the peptide solution (5 μM) at pH 4.
Bilayers with the peptide solution were allowed an additional 6 hour equilibration.
Measurements were taken at 3 steps during the process: when the monolayers were
incubated with the excess of liposomes, soon after spaces between slides were filled
with the peptide solution and 6 hours after the second measurement. 14 slides (28
bilayers) were assembled and OCD spectra were recorded on a MOS-450 spectrometer
with 2 s sampling time. Control measurements were carried out of the peptide between
slides with and without supported bilayers and in the presence of an excess of POPC
liposomes.

Assumptions made for the analysis of pH-dependence data
Peptide intrinsic fluorescence changes are used to follow the insertion as a function of
pH (transition from the state II to state III as the pH is lowered). Decomposition of the
fluorescence spectra measured at various pHs gives the positions of the maxima, and
the single component solutions are shown. The Henderson–Hasselbalch equation with
cooperativity was used to fit the experimental points, and the fitting curves and 95%
confidence intervals are shown by the red and blue lines, respectively. Each graph
notes the apparent pK of the peptide’s insertion into the membrane obtained from the
fitting of the experimental data. The pKa of Var0 (WT-pHLIP) is 6.0. The pKa values

178

obtained by fitting of the experimental data by the Henderson–Hasselbalch equation
with a fixed cooperativity parameter (n=1) are very similar to the data shown in the
figure: Var1=6.14; Var2=5.59; Var3=5.09; Var4=5.32; Var5=4.84; Var6=5.06;
Var7=5.51;

Var8=5.75;

Var9=5.59;

Var10=4.92;

Var11=5.52;

Var12=4.52;

Var13=5.16; Var14=5.69; Var15=5.59; Var16=5.63. It is assumed that there is a linear
relation between the position of the maximum and the contribution of state II (or state
III) (state I is the peptide in solution at pH8; state II is the peptide in the presence of
POPC liposomes at pH8; state III is the result of folding and insertion of the peptide
with POPC when the pH is dropped from 8 to 3.6 by the addition of an aliquot of
HCl). However, due to the fact that the quantum yields in states II and III are slightly
different, there was a slight non-linearity, so we completed the analysis by estimating
the contributions of the states for WT-pHLIP and found that the apparent pK shifts no
more than on 0.05 pH units toward lower pHs. Since this shift is less than the
experimental error, we present the pKa values for transitions from the state II to III
based on the analysis of the positions of spectral maxima.

Quantification of cellular uptake
For quantification of cellular uptake of BODIPY-labeled Var3 and Var7 at pH7.4 and
5.9 we used A549-GFP cells in suspension. 2 μM of fluorescently labeled peptides
were incubated with cells in DMEM media at pH7.4 and 5.9 for 30 min at 37°C and
5% CO2. Then, cells were pelleted by centrifugation (2000 rpm, 4 min) at room
temperature, the supernatant was removed and the pellet was washed three times with
the same media and resuspended in 50 µL, and the cell suspension solution was placed
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into cell counting chambers. The phase-contrast, GFP and BODIPY fluorescent
signals were measured and analyzed using ImagePro Plus program.

Biophysical properties, which affect tumor targeting
- The apparent pK of peptide insertion into membrane determines the proportion of
available peptide molecules inserted into plasma membrane of cancer cells at various
pHs. Currently we have pHLIP peptides with pKas varying over the range from 4.5 to
6.5 for insertion into POPC lipid bilayers. Various pHLIP variants might be used to
probe the pHs of more or less acidic tumors. The insertion of pHLIP responds to the
pH at the surfaces of cancer cells, not that of the surrounding fluid. Due to the
transmembrane potential gradient, protons accumulate at the surfaces of cells in close
vicinity of membrane, and the pH is lower than in the bulk extracellular environment
or in blood. Current methods of measuring pH in vivo report the average value of
extracellular pH in tumors, which can vary from 6.0 to 7.2, but the pH at the surfaces
of cancer cells are likely to be lower.
- pHLIP is a relatively hydrophobic peptide, therefore significant initial association with
a lipid bilayer or plasma membrane occurs at neutral pH. The strength of this
interaction (state II) is determined by the balance of hydrophobic and polar/charged
residues in the pHLIP sequence. Stronger partitioning of the peptides onto bilayers at
neutral pH increases the time of circulation in the blood. Long circulation time is a
disadvantage for SPECT/PET imaging, since the short half-life-time probes are used
and tumor targeting and blood clearance need to be very fast (at least within 4 hours).
However, long circulation times of pHLIP variants in the blood could be very well
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suited for fluorescence or MR imaging, as well as for the delivery of therapeutic
agents. We find that all pHLIP variants that have higher affinities for membranes at
neutral pH show high tumor/organ ratios at 24 hours post-injection.
- An important parameter is the difference between the Gibbs free energy of peptide
binding to membranes at low pH vs. high pH. This parameter reflects the difference in
the affinity of the peptide to membrane at low and neutral pH and the strength of
formation of transmembrane helix at low pH. A larger ΔΔG will ensure a greater
differentiation between the inserted and non-inserted peptides as a function of pH.
- For applications in vivo, the kinetics of peptide insertion across the lipid bilayer are
important for rapid equilibration with tissues and clearance from the blood. Based on
insertion kinetics we can group all pHLIP peptides into: i) the peptides with
protonatable residues both in the TM and in the inserting end show the slowest
kinetics of insertion (minutes); ii) peptides that are truncated at the inserting end and
have few or no protonatable residues at the inserting end, partition in bilayer much
faster (seconds), iii) peptides that have protonatable residues at the inserting end but
not in the TM show intermediate times of insertion (~20 s), and finally, peptides with
only one protonatable residue in the TM have the fastest kinetics of insertion, which
coincides with time of formation of helical structure (~100 msec).
- Exit kinetics should be different in cells and liposomes, since peptides that have
protonatable residues that are translocated across a cell membrane move them to the
neutral pH of the cytoplasm. To exit the cell membrane, these groups must be
protonated, which is much less likely in the cytoplasm, so these peptides become
anchored in a cell. Such an “anchor” can significantly (by orders of magnitude)
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reduce the rate of peptide exit, and the peptide could stay in the plasma membrane for
weeks. Such an effect would explain our observation that mouse tumors are stably
labeled with fluorescent WT-pHLIP.
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Tables
Parameter
s

Nam
e
Var1

max
S
225 x103

Var2

Var3

Var4

Var5

Var6

Var7

Var8

State I

State II

State
III

349
1
-2.42

345
1.47
-3.85

339
1.81
-9.46

350
1
-2.74
353
1
-2.07
353
1
-2.32
351
1
-2.20
353
1
-2.12
352
1
-2.64
353
1
-0.89

345
2.08
-3.76
347
1.66
-3.94
340
2.66
-10.14
355
2.05
-3.38
350
0.96
-2.89
345
1.74
-4.12
353
1.19
-1.22

342
2.76
-8.64
338
2.08
-13.49
345
3.32
-15.28
340
3.52
-6.25
339
1.64
-6.95
340
3.08
-8.82
337
2.48
-9.43

Name

State I

State II

State
III

Var9

353
1
-2.39

350
1.28
-3.20

339
2.10
-7.90

350
1
-2.40
351
1
-2.14
353
1
-0.82
355
1
-1.76
351
1
-2.00
351
1
-4.30
346
1
-5.41

347
1.47
-2.46
345
2.60
-3.08
352
1.36
-0.96
349
1.72
-2.28
346
1.54
-3.79
339
2.14
-8.94
345
1.89
-7.03

340
2.86
-8.40
340
3.20
-9.02
341
2.90
-4.80
340
3.61
-6.14
344
2.94
-9.91
339
2.52
-10.08
339
2.14
-8.57

Var10

Var11

Var12

Var13

Var14

Var15

Var16

Table S1. The three states of each pHLIP variant. The spectral parameters of the
pHLIP variants in states I, II and III are presented. The parameters were obtained from
analysis of the fluorescence and CD spectra shown in Figure 1: the maximum position
of the fluorescence spectrum max, in nm; S – the normalized area under the spectra
(normalization was done on the area under the spectrum in State I); 225 x 103, deg cm2
dmol-1 – the molar ellipticity at 225 nm.
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Kidney
Tumor
Heart
Lungs
Liver
Spleen
Bladder
Stomach
Intestine
Muscle
Brain

Var0-WT
n=9
3630.6485.6
1373.8334.5
621.4152.3
1003.6297.5
1651.4470.2
546.4131.4
825.4495.8
909.2277.1
884.2260.5
476.8110.1
270.146.3

Var1-2D1D
n=6
4324.0444.6
1812.4819.0
752.9398.4
1016.6567.7
2309.71457.0
757.5445.0
1030.5646.3
1249.6783.1
1116.4646.0
766.5285.3
303.1113.3

Var2-2D1D
n=5
3456.3585.4
1145.3737.5
554.6421.2
761.1506.8
1432.4950.8
539.3372.3
665.3486.4
1092.0793.5
590.9347.0
413.7248.9
233.572.9

Var3-3D
n=7
6125.61004.1
3054.9726.2
855.0331.6
803.1256.2
1829.6741.6
675.6244.6
1104.6628.7
1029.6355.0
574.3221.9
541.9180.3
350.695.6

Var4-3E
n=4
6755.6698.7
2439.3443.2
980.5187.3
1077.384.2
3615.31099.4
987.3320.8
1198.8719.3
1239.8438.8
888.5442.9
629.897.9
372.313.9

Kidney
Tumor
Heart
Lungs
Liver
Spleen
Bladder
Stomach
Intestine
Muscle
Brain

Var6-3Db
n=5
2536.1297.2
461.671.6
262.229.5
266.423.7
414.831.8
316.050.6
298.638.3
268.631.2
246.435.0
220.830.0
180.218.7

Var7-3Ea
n = 16
3583.3427.9
970.1449.1
351.181.0
413.3135.6
695.1244.2
479.3310.6
554.4243.4
605.6205.6
437.8109.2
277.867.2
206.336.0

Var8-3Eb
n=5
3729.2749.0
910.6180.1
515.0284.4
526.062.2
938.279.2
443.886.8
608.8113.3
563.493.3
380.687.7
339.050.7
230.218.4

Var9-3Ec
n=5
3367.9667.6
1169.4297.9
613.4250.6
958.0367.2
1309.2255.3
629.296.1
942.0204.0
934.2251.3
471.898.9
450.897.8
222.016.7

Var10-2D
n=6
3575.0540.4
819.9306.7
341.587.7
412.842.4
539.0114.3
423.429.3
420.077.3
513.170.2
321.6109.2
281.570.0
217.426.4

Kidney
Tumor
Heart
Lungs
Liver
Spleen
Bladder
Stomach
Intestine
Muscle
Brain

Var12-1D
n=7
2004.5527.7
614.5186.7
368.7100.4
423.8122.0
435.9139.0
295.775.5
287.251.5
341.284.6
227.559.0
270.830.7
207.033.0

Var13-1E
n=6
2653.7357.1
459.099.3
351.761.5
349.778.9
457.246.8
365.220.4
414.7102.9
483.396.1
277.831.1
261.824.4
211.013.5

Var14-Rev
n=5
4162.9210.7
1245.0308.7
691.0104.7
808.2116.3
1863.0312.6
527.864.6
648.6235.5
685.6101.3
839.8196.9
421.435.8
290.627.2

Var15-2N
n=5
5657.0843.8
2075.8252.2
837.6188.0
1190.8419.3
1888.8303.1
717.461.9
743.659.8
556.694.6
720.452.9
500.637.1
405.065.5

Var16-2P
n=6
3733.0582.9
1407.0142.1
342.728.9
451.085.2
1344.0153.2
370.724.0
525.7121.2
361.261.5
403.367.3
396.037.8
216.714.9

Var5-3Da
n=5
3097.0528.3
559.495.6
334.043.4
405.434.5
561.2103.0
432.263.0
452.447.6
470.871.7
257.623.0
250.617.9
193.213.5

Var11-2E
n=6
4164.3833.5
981.0357.9
532.3104.5
560.242.2
744.257.1
495.746.5
623.0145.3
763.0107.8
353.314.7
330.222.2
241.524.7

Table S2. Mean NIR fluorescence with standard deviation calculated for each organ
collected at 4 hours after Alexa750-pHLIP variant administration, n is the number of
animals. The mean fluorescence values of organs were normalized to the signal in
kidney for each mouse, then averaged for each variant and presented in Figure S3.
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Kidney
Tumor
Heart
Lungs
Liver
Spleen
Bladder
Stomach
Intestine
Muscle
Brain

Var0-WT
n=9
854.4186.9
818.8157.4
248.533.3
355.738.8
602.2104.4
226.113.0
250.227.5
248.933.1
270.240.5
197.631.0
166.310.8

Var1-2D1D
n=4
3349.52262.1
1366.1776.7
580.9280.2
758.3422.8
2211.1973.9
626.3368.0
861.6743.0
884.0619.8
808.7473.3
555.4320.9
253.573.8

Var2-2D1D
n=9
1525.2472.4
881.4560.6
240.394.3
351.9190.9
660.8427.5
285.3170.8
301.3183.5
353.2178.4
237.275.3
213.588.9
164.830.8

Var3-3D
n=7
1141.8416.7
950.9434.1
186.031.3
190.431.8
366.372.0
199.025.5
221.633.2
198.418.2
184.319.5
158.721.6
147.78.1

Var4-3E
n=3
1151.4262.4
1106.3651.1
255.075.1
287.793.6
737.390.4
249.330.7
282.372.8
257.028.0
261.334.8
185.345.1
163.024.3

Var5-3Da
n=5
431.0121.5
252.267.6
166.016.0
198.615.3
209.018.2
184.014.5
188.010.8
201.816.3
141.62.1
141.45.1
136.83.2

Kidney
Tumor
Heart
Lungs
Liver
Spleen
Bladder
Stomach
Intestine
Muscle
Brain

Var6-3Db
n=5
380.546.0
218.640.8
142.84.9
148.88.4
220.25.7
164. 69.0
156.010.8
152.04.3
141.43.8
134.21.8
137.62.9

Var7-3Ea
n = 17
785.3200.9
453.1173.2
173.320.3
181.624.2
299.851.7
200.122.6
187.223.5
185.826.2
207.828.9
154.515.0
147.87.5

Var8-3Eb
n=5
1287.1307.6
441.6102.0
201.819.8
330.276.0
455.676.9
244.839.1
236.837.7
249.459.1
192.614.2
171.615.7
154.66.7

Var9-3Ec
n=5
1242.2280.6
441.253.9
247.092.6
270.658.6
536.0101.4
273.67.3
264.230.6
258.238.2
233.019.8
182.28.1
159.07.4

Var10-2D
n=5
1013.5104.4
345.1140.2
196.879.3
198.417.3
338.347.5
217.071.8
207.460.2
227.989.2
194.473.3
180.664.6
165.530.7

Var11-2E
n=4
828.6129.1
400.361.0
186.310.6
207. 38.7
285.512.4
204.315.1
214.318.2
198.59.3
173.09.5
173.06.1
157.82.6

Kidney
Tumor
Heart
Lungs
Liver
Spleen
Bladder
Stomach
Intestine
Muscle
Brain

Var12-1D
n=6
469.872.1
323.793.8
202.723.7
221.130.7
252.332.9
165.898.0
242.726.6
197.423.9
166.720.0
184.628.2
159.517.9

Var13-1E
n=3
444.988.9
218.315.1
157.76.7
184.78.3
224.021.9
158.310.4
188.016.6
170.311.7
152.712.1
147.77.4
146.72.5

Var14-Rev
n=5
1157.4147.5
867.4286.1
230.823.7
285.467.0
567.2130.6
221.640.7
274.636.8
189.822.2
289.472.0
188.825.9
168.614.0

Var15-2N
n=5
1618.9283.3
1416.0468.6
370.852.3
473.268.9
742.850.2
295.834.5
417.626.6
288.655.5
296.036.8
260.814.3
214.29.3

Var16-2P
n=6
819.3124.1
575.5231.1
164.220.1
171.329.5
421.552.7
183.313.9
166.711.2
166.520.7
168.37.1
147.07.4
145.06.9

Table S3. Mean NIR fluorescence with standard deviation calculated for each organ
collected at 24 hours after administration of Alexa750-pHLIP variants, n is the
number of animals. The mean fluorescence values of each organ was normalized to
the signal in kidney at 4 hours (Table S2) for each mouse, then averaged for each
variant and presented in Figure S3.
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Kidney
Tumor
Heart
Lungs
Liver
Spleen
Bladder
Stomach
Intestine
Muscle
Brain

K-Var3, 4h
n = 11
921.6306.2
395.9107.6
319.6140.2
296.166.9
2637. 6446.4
1057.5416.6
331.1100.1
286.270.0
298.746.0
201.329.9
192.525.9

K-Var3, 24h
n=8
254.591.9
220.070.0
165.451.1
154.116.0
684.2138.5
284.332.0
176.526.7
168.420.2
173.914.5
141.115.6
139.75.9

K-Var7, 4h
n = 10
852.5345.0
306.0107.6
228.256.2
225.080.0
1920.4752.3
552.3140.8
265.470.9
260.684.0
289.784.9
178.831.4
158.828.5

K-Var7, 24h
n = 10
235.215.5
185.79.8
156.427.7
136.210.7
538.265.2
255.280.1
155.311.0
156.715.5
166.99.7
127.74.2
134.32.9

Table S4. Mean NIR fluorescence with standard deviation calculated for each organ
collected at 4 and 24 hours after Alexa750-K-pHLIP variant administration, n is the
number of animals.

Kidney
Tumor
Heart
Lungs
Liver
Spleen
Bladder
Stomach
Intestine
Muscle
Brain

Var3, 4h
n=4
154.314.4
325.011.4
128.38.1
127.511.4
391.578.9
122.03.9
241.723.8
257.066.2
197.826.7
150.56.8
142.013.0

K-Var3, 4h
n=4
128.810.6
151.516.7
114.56.0
116.07.0
152.819.8
118.34.5
150.819.3
233.075.2
159.042.3
126.83.0
135.311.8

Var7, 4h
n=4
189.551.0
308.0115.8
124.013.1
124.011.6
210.567.6
125.010.4
233.064.6
269.876.6
222.5118.3
141.020.5
131.523.5

K-Var7, 4h
n=4
121.34.6
136.39.3
111.53.5
111.01.4
142.330.5
113.04.2
143.818.8
212.526.6
133.019.3
119.34.8
130.57.9

Table S5. Mean NIR fluorescence with standard deviation calculated for each organ
collected at 4 hours after BODIPY-labeled Var3, K-Var3, Var7 and K-Var7
administration, n is the number of animals.
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Figures

Figure S1. Three states of pHLIP variants. The pHLIP variants were studied for
the presence of the three basic states of pHLIP: state I is the peptide in solution at
pH8; state II is the peptide in the presence of POPC liposomes at pH8; state III is the
folding and insertion of the peptide
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Figure S2. Comparison of the kinetics of WT-pHLIP and Alexa750-WT-pHLIP
insertion into membrane. The changes of tryptophan fluorescence signal of
Alexa750-WT-pHLIP in presence of POPC liposome in a result of pH drop from 8 to
4-5 was recorded in a stopped-flow apparatus, multiplied by (-1), normalized and
compared with the kinetics of insertion of non-labeled WT.
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Figure S3. Distribution of Alexa750-pHLIP in organs and tumors. Normalized
mean NIR fluorescence of tumor and organs at 4 and 24 hours after construct
administration are shown (the signals in kidney at 4 hours are taken as 100%). The
non-normalized values of fluorescence are given in Supplementary Tables S2 and S3.
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Figure S4. Cellular uptake of BODIPY labeled Var3, Var7, K-Var3 and K-Var7.
Fluorescence and phase-contrast images of cells treated with fluorescence peptides at
pH7.4 and 5.9 for 30 min and washed 4-5 times of the same media are shown. Also
cell experiments were carried out with Alexa750-labeled Var3, Var7, K-Var3 and KVar7. Despite the fact that the signal was low (due to the low NIR sensitivity of the
Retiga CCD camera) the distribution of the signal in cells was the same as in the case
of Rho and BODIPY-labeled peptides.
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